|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
JPS5896026A
(ja)
|
1981-10-30 |
1983-06-07 |
Nippon Chemiphar Co Ltd |
新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤
|
|
EP0098110B1
(en)
|
1982-06-24 |
1989-10-18 |
NIHON CHEMICAL RESEARCH KABUSHIKI KAISHA also known as JAPAN CHEMICAL RESEARCH CO., LTD |
Long-acting composition
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
EP0206448B1
(en)
|
1985-06-19 |
1990-11-14 |
Ajinomoto Co., Inc. |
Hemoglobin combined with a poly(alkylene oxide)
|
|
US4766106A
(en)
|
1985-06-26 |
1988-08-23 |
Cetus Corporation |
Solubilization of proteins for pharmaceutical compositions using polymer conjugation
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
US5567610A
(en)
|
1986-09-04 |
1996-10-22 |
Bioinvent International Ab |
Method of producing human monoclonal antibodies and kit therefor
|
|
JPH01207920A
(ja)
|
1988-02-16 |
1989-08-21 |
Oki Electric Ind Co Ltd |
ＩｎＰ半導体薄膜の製造方法
|
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5270202A
(en)
|
1989-11-03 |
1993-12-14 |
Syamal Raychaudhuri |
Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen
|
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5229275A
(en)
|
1990-04-26 |
1993-07-20 |
Akzo N.V. |
In-vitro method for producing antigen-specific human monoclonal antibodies
|
|
IE911869A1
(en)
|
1990-06-01 |
1991-12-04 |
Regeneron Pharma |
A family of map2 protein kinases
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5780587A
(en)
|
1990-08-24 |
1998-07-14 |
President And Fellows Of Harvard College |
Compounds and methods for inhibiting β-protein filament formation and neurotoxicity
|
|
EP1243652A3
(en)
|
1991-09-20 |
2003-03-26 |
Amgen Inc., |
Glial derived neurotrophic factor
|
|
US5412087A
(en)
|
1992-04-24 |
1995-05-02 |
Affymax Technologies N.V. |
Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces
|
|
AU3178993A
(en)
|
1991-11-25 |
1993-06-28 |
Enzon, Inc. |
Multivalent antigen-binding proteins
|
|
DE69233723T2
(de)
|
1991-12-06 |
2009-02-05 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Verwendung von Proteinkinasen zur Diagnose und Behandlung der Alzheimer Krankheit
|
|
US5624807A
(en)
|
1992-07-22 |
1997-04-29 |
The Mclean Hospital Corporation |
Methods for detecting Alzheimer's disease by measuring ratios of calcium-activated neutral protease isoforms
|
|
JP3720353B2
(ja)
|
1992-12-04 |
2005-11-24 |
メディカル リサーチ カウンシル |
多価および多重特異性の結合タンパク質、それらの製造および使用
|
|
WO1994021293A1
(en)
|
1993-03-19 |
1994-09-29 |
Duke University |
Method of treatment of tumors with an antibody binding to tenascin
|
|
EP0728215B1
(en)
|
1993-10-20 |
2002-02-20 |
Duke University |
METHOD OF BINDING MATERIAL TO THE Beta-AMYLOID PEPTIDE
|
|
US5985660A
(en)
|
1994-06-15 |
1999-11-16 |
Systemix, Inc. |
Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation and/or differentiation
|
|
CU22615A1
(es)
|
1994-06-30 |
2000-02-10 |
Centro Inmunologia Molecular |
Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos
|
|
ATE306930T1
(de)
|
1994-08-12 |
2005-11-15 |
Immunomedics Inc |
Für b-zell-lymphom und leukämiezellen spezifische immunkonjugate und humane antikörper
|
|
JPH10504961A
(ja)
|
1994-08-26 |
1998-05-19 |
ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド |
Ｇａｂａ▲下ａ▼レセプターイプシロンサブユニット
|
|
HUT77081A
(hu)
|
1994-10-28 |
1998-03-02 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Protein kináz NPK-110
|
|
US6835555B1
(en)
|
1994-11-01 |
2004-12-28 |
Human Genome Sciences, Inc. |
Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
|
|
US7427392B1
(en)
|
1994-11-14 |
2008-09-23 |
Elan Pharmaceuticals, Inc. |
Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
|
|
DE4447287C1
(de)
|
1994-12-30 |
1996-11-07 |
Cevc Gregor |
Präparat zum Wirkstofftransport durch Barrieren
|
|
US5650313A
(en)
|
1995-06-05 |
1997-07-22 |
Human Genome Sciences, Inc. |
Ubiquitin conjugating enzymes 8 and 9
|
|
US5786180A
(en)
|
1995-02-14 |
1998-07-28 |
Bayer Corporation |
Monoclonal antibody 369.2B specific for β A4 peptide
|
|
GB9506197D0
(en)
|
1995-03-27 |
1995-05-17 |
Hoffmann La Roche |
Inhibition of tau-tau association.
|
|
US6576607B1
(en)
|
1995-04-19 |
2003-06-10 |
Acorda Therapeutics |
Methods using CNS neurite outgrowth modulators
|
|
US5986054A
(en)
|
1995-04-28 |
1999-11-16 |
The Hospital For Sick Children, Hsc Research And Development Limited Partnership |
Genetic sequences and proteins related to alzheimer's disease
|
|
US6221645B1
(en)
|
1995-06-07 |
2001-04-24 |
Elan Pharmaceuticals, Inc. |
β-secretase antibody
|
|
DE69635207T2
(de)
|
1995-07-07 |
2006-06-22 |
Darwin Molecular Corp. |
Auf Chromosom 1 lokalisiertes Gen dessen Genprodukt mit der Alzheimerschen Krankheit assoziiert ist.
|
|
US6156311A
(en)
|
1995-07-27 |
2000-12-05 |
The American National Red Cross |
Modulators of expression and function of LRP in alzheimer's disease
|
|
US5695937A
(en)
|
1995-09-12 |
1997-12-09 |
The Johns Hopkins University School Of Medicine |
Method for serial analysis of gene expression
|
|
FR2741892B1
(fr)
|
1995-12-04 |
1998-02-13 |
Pasteur Merieux Serums Vacc |
Procede de preparation d'une banque multicombinatoire de vecteurs d'expression de genes d'anticorps, banque et systemes d'expression d'anticorps "coliclonaux" obtenus
|
|
US5936078A
(en)
|
1995-12-12 |
1999-08-10 |
Kyowa Hakko Kogyo Co., Ltd. |
DNA and protein for the diagnosis and treatment of Alzheimer's disease
|
|
AUPN896596A0
(en)
|
1996-03-27 |
1996-04-26 |
Walter And Eliza Hall Institute Of Medical Research, The |
Therapeutic molecules
|
|
WO1997037228A1
(en)
|
1996-03-29 |
1997-10-09 |
The Trustees Of Boston University |
Methods for diagnosing and treating alzheimer's disease
|
|
US6455277B1
(en)
|
1996-04-22 |
2002-09-24 |
Amgen Inc. |
Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides
|
|
US5663059A
(en)
|
1996-05-10 |
1997-09-02 |
Incyte Pharmaceuticals, Inc. |
Human phospholipase inhibitor
|
|
US6010878A
(en)
|
1996-05-20 |
2000-01-04 |
Smithkline Beecham Corporation |
Interleukin-1 β converting enzyme like apoptotic protease-6
|
|
CA2183901A1
(en)
|
1996-08-22 |
1998-02-23 |
Johanna E. Bergmann |
Targets for therapy and diagnosis of alzheimer's disease and down syndrome in humans
|
|
PT966533E
(pt)
|
1997-02-07 |
2010-01-26 |
Univ Ramot |
Factor neurotrófico iii dependente da actividade (adnf iii)
|
|
US6413940B1
(en)
|
1997-02-07 |
2002-07-02 |
Nymox Corporation |
Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis of DMS
|
|
US6087153A
(en)
|
1997-07-24 |
2000-07-11 |
The Trustees Of Columbia University In The City Of New York |
Sel-10 and uses thereof
|
|
IT1293511B1
(it)
|
1997-07-30 |
1999-03-01 |
Gentili Ist Spa |
Anticorpi monoclonali catalitici ad attivita' proteasica per la lisi selettiva della componente proteica di placche e aggregati correlati
|
|
US7384910B2
(en)
|
1997-10-08 |
2008-06-10 |
Castillo Gerardo M |
Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
|
|
US6242421B1
(en)
|
1997-11-06 |
2001-06-05 |
Richard Lloyd Bowen |
Methods for preventing and treating Alzheimer's disease
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US7189703B2
(en)
|
1998-01-09 |
2007-03-13 |
Intracell, Llc |
Treatment and diagnosis of alzheimer's disease
|
|
GB9816575D0
(en)
|
1998-07-31 |
1998-09-30 |
Zeneca Ltd |
Novel compounds
|
|
EP1104307B1
(en)
|
1998-08-06 |
2006-06-07 |
Teijin Limited |
Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix
|
|
US20050032675A1
(en)
|
1998-08-06 |
2005-02-10 |
Teijin Limited |
Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix
|
|
GB9818731D0
(en)
|
1998-08-27 |
1998-10-21 |
Univ Portsmouth |
Compounds
|
|
ES2260570T3
(es)
|
1998-08-27 |
2006-11-01 |
Spirogen Limited |
Pirrolobenziodiazepinas dimericas.
|
|
GB9818730D0
(en)
|
1998-08-27 |
1998-10-21 |
Univ Portsmouth |
Collections of compounds
|
|
KR100640265B1
(ko)
|
1998-09-17 |
2006-10-31 |
오츠카 세이야쿠 가부시키가이샤 |
Ｌｙ6ｈ 유전자
|
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
CA2353795A1
(en)
|
1998-12-02 |
2000-06-08 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases
|
|
US6982089B2
(en)
|
1999-02-24 |
2006-01-03 |
Tact Ip, Llc |
Cytokine antagonists for neurological and neuropsychiatric disorders
|
|
DE19909357A1
(de)
|
1999-03-03 |
2000-09-07 |
Gerd Multhaup |
Kupferagonist, der an die Kupferbindungsstelle von APP bindet und/oder eine hemmende Wirkung auf die Freisetzung des Amyloid-Aß-Peptids ausübt
|
|
DE19910108C2
(de)
|
1999-03-08 |
2001-02-22 |
Falk Fahrenholz |
Zellen, die ein Amyloidvorläuferprotein und eine alpha-Sekretase coexprimieren, ein Testverfahren zur Identifikation alpha-Sekretase-aktiver Substanzen sowie eines zur Identifikation weiterer Sekretasen, ein Testverfahren zur Bestimmung der Anfälligkeit gegenüber Morbus Alzheimer und Verwendung von Nukleinsäuren, die für eine alpha-Sekretase codieren, für die Gentherapie
|
|
AU4055000A
(en)
|
1999-04-13 |
2000-11-14 |
Daniel K. Hsu |
Galectin expression is induced in cirrhotic liver and hepatocellular carcinoma
|
|
US6303576B1
(en)
|
1999-04-21 |
2001-10-16 |
Adherex Technologies Inc. |
Compounds and methods for modulating β-catenin mediated gene expression
|
|
UA81216C2
(en)
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
|
CA2378485A1
(en)
|
1999-07-08 |
2001-01-18 |
Helix Research Institute |
Proliferation differentiation factor
|
|
EP1074634B1
(en)
|
1999-07-09 |
2002-10-02 |
Institut Pasteur De Lille |
Method for the diagnosis or the prognosis of Alzheimer disease therapeutical composition for preventing or treating Alzheimer disease
|
|
CA2388341A1
(en)
|
1999-08-06 |
2001-02-15 |
S.I.S.S.A. Scuola Internazionale Superiore Di Studi Avanzati |
Non-human transgenic animals for the study of neurodegenerative syndromes
|
|
ES2344189T3
(es)
|
1999-09-03 |
2010-08-20 |
RAMOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH & INDUSTRIAL DEVELOPMENT LTD. |
Agentes, composiciones y metodos que los utilizan utiles en el tratamiento o la prevencion de la enfermedad de alzheimer.
|
|
US6255054B1
(en)
|
1999-09-09 |
2001-07-03 |
Jacques Hugon |
Polymorphism of the human GluR-5 gene and risk factor for alzheimer disease
|
|
JP4969006B2
(ja)
|
1999-09-17 |
2012-07-04 |
学校法人慶應義塾 |
神経細胞死を抑制するポリペプチド、Ｈｕｍａｎｉｎ
|
|
US20020094335A1
(en)
|
1999-11-29 |
2002-07-18 |
Robert Chalifour |
Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
|
|
ATE490979T1
(de)
|
2000-02-14 |
2010-12-15 |
Takeshi Iwatsubo |
Neueskollagen-ähnliches protein clac, dessen vorläufer und dafür kodierende gene
|
|
MXPA02008145A
(es)
|
2000-02-24 |
2004-04-05 |
Univ Washington |
Anticuerpos humanizados que secuestran al peptido beta amiloide.
|
|
US20060148712A1
(en)
|
2000-03-13 |
2006-07-06 |
Fu-Tong Liu |
Monocyte chemoattractant activity of galectin-3
|
|
US7186681B2
(en)
|
2000-03-13 |
2007-03-06 |
La Jolla Institute For Allergy And Immunology |
Methods of modulating cell migration using galectin-3
|
|
ES2389811T3
(es)
|
2000-06-28 |
2012-10-31 |
Prana Biotechnology Limited |
Oligómeros de amiloide beta para uso en el tratamiento, el alivio o la prevención de la enfermedad de Alzheimer
|
|
PE20020276A1
(es)
|
2000-06-30 |
2002-04-06 |
Elan Pharm Inc |
COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
|
|
JP5362164B2
(ja)
|
2000-07-07 |
2013-12-11 |
バイオアークティック ニューロサイエンス アーベー |
アルツハイマー病の予防及び治療
|
|
US6825164B1
(en)
|
2000-08-14 |
2004-11-30 |
The Trustees Of Columbia University In The City Of New York |
Method to increase cerebral blood flow in amyloid angiopathy
|
|
US6730905B2
(en)
|
2000-09-21 |
2004-05-04 |
Matsushita Electric Industrial Co., Ltd. |
Scanning probe microscopy, method of producing the probe, and molecular processing method using the scanning probe microscope
|
|
US7471798B2
(en)
*
|
2000-09-29 |
2008-12-30 |
Knowles Electronics, Llc |
Microphone array having a second order directional pattern
|
|
KR100395254B1
(ko)
|
2000-10-30 |
2003-08-21 |
(주)자리타 바이오텍 |
종양 발생 예측 키트
|
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US7264810B2
(en)
|
2001-01-19 |
2007-09-04 |
Cytos Biotechnology Ag |
Molecular antigen array
|
|
AT500379B8
(de)
|
2001-02-02 |
2009-08-15 |
Axon Neuroscience |
Tau-proteine
|
|
CN1549721B
(zh)
|
2001-02-27 |
2012-03-07 |
布朗歇特洛克菲勒神经科学研究所 |
基于促分裂原活化的蛋白激酶的磷酸化诊断阿尔茨海默氏病
|
|
DE10117281A1
(de)
|
2001-04-06 |
2002-10-24 |
Inst Molekulare Biotechnologie |
Peptid zur Diagnose und Therapie der Alzheimer-Demenz
|
|
US20040157225A1
(en)
|
2001-04-14 |
2004-08-12 |
Rainer Hipfel |
Diagnostic and therapeutic use of a nuclear restricted protein for alzheimer's disease and related neurodegenerative disorders
|
|
ES2437875T3
(es)
|
2001-04-30 |
2014-01-14 |
Eli Lilly And Company |
Anticuerpos humanizados que reconocen el péptido beta-amiloide
|
|
US6884869B2
(en)
|
2001-04-30 |
2005-04-26 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
US6906169B2
(en)
|
2001-05-25 |
2005-06-14 |
United Biomedical, Inc. |
Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
|
|
DE10130166A1
(de)
|
2001-06-22 |
2003-01-16 |
Elegene Ag I Ins |
Identifizierung von ses-1 sowie dessen Verwendungen
|
|
DE10130247A1
(de)
|
2001-06-22 |
2003-01-16 |
Elegene Ag I Ins |
Identifizierung von ses-3 sowie dessen Verwendungen
|
|
US6831699B2
(en)
|
2001-07-11 |
2004-12-14 |
Chang Industry, Inc. |
Deployable monitoring device having self-righting housing and associated method
|
|
EP1420032B2
(en)
|
2001-08-03 |
2015-12-16 |
Medical & Biological Laboratories Co., Ltd. |
Antibody recognizing gm1 ganglioside-bound amyloid beta-protein and dna encoding the antibody
|
|
DE60235996D1
(de)
|
2001-09-07 |
2010-05-27 |
Takeda Pharmaceutical |
Diagnostische und therapeutische verwendung von f-box-proteinen bei morbus alzheimer und verwandten neurodegenerativen erkrankungen
|
|
US6716821B2
(en)
|
2001-12-21 |
2004-04-06 |
Immunogen Inc. |
Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
|
|
DE60303360T2
(de)
|
2002-02-14 |
2006-09-21 |
Evotec Neurosciences Gmbh |
Diagnostische und therapeutische verwendung des caps
|
|
ATE352564T1
(de)
|
2002-03-04 |
2007-02-15 |
Nymox Corp |
Spheron-komponenten für die bestimmung von verbindungen, die symptome der alzheimer krankheit behandeln können, ihre behandlungen und tiermodelle
|
|
ES2392247T3
(es)
|
2002-03-05 |
2012-12-07 |
Ramot At Tel-Aviv University Ltd. |
Compuesto inmunizante y método para inducir una respuesta inmune contra el sitio de escisión de la beta-secretasa de la proteína precursora de amiloide
|
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
ATE365175T1
(de)
|
2002-03-21 |
2007-07-15 |
Evotec Neurosciences Gmbh |
Diagnostische und therapeutische verwendung von humanen maguinproteinen und nukleinsäuren bei neurodegenerativen krankheiten
|
|
ES2368907T3
(es)
|
2002-04-19 |
2011-11-23 |
The Governing Council Of The University Of Toronto |
Procedimientos y composiciones inmunológicas para el tratamiento de la enfermedad de alzheimer.
|
|
ATE449964T1
(de)
|
2002-04-24 |
2009-12-15 |
Evotec Neurosciences Gmbh |
DIAGNOSTISCHE VERWENDUNG VON ßENSADIN-0477ß FÜR NEURODEGENERATIVE ERKRANKUNGEN
|
|
US20050032673A1
(en)
*
|
2002-06-10 |
2005-02-10 |
John Constance M. |
Sustained release N-terminally truncated galectin-3 and antibodies to galectin-3 carbohydrate ligands for use in treating disease
|
|
US7409040B2
(en)
|
2002-06-21 |
2008-08-05 |
Reuven Avrohom Cyrulnik |
System and method for noninvasive diagnostic imaging, detection, and identification of substances by microwave/RF modulation of x-rays and applications in treatment of diseases characterized by the presence of pathological macromolecules or by the need for regeneration of normal tissue
|
|
DE60317671T2
(de)
|
2002-06-27 |
2008-10-30 |
Evotec Neurosciences Gmbh |
Diagnostische und therapeutische verwendung von ensadin-0581 gen und protein für neurodegenerative erkrankungen
|
|
US7141137B2
(en)
|
2002-07-10 |
2006-11-28 |
University Of Maine System Board Of Trustees |
Method of making laminated wood beams with varying lamination thickness throughout the thickness of the beam
|
|
EP1521774B1
(en)
|
2002-07-12 |
2008-08-27 |
Axon Neuroscience Forschungs- und Entwicklungs Gmbh |
Truncated tau proteins
|
|
CN101711865A
(zh)
|
2002-07-19 |
2010-05-26 |
希托斯生物技术股份公司 |
含有淀粉样β1-6抗原阵列的疫苗组合物
|
|
SI1545613T1
(sl)
|
2002-07-31 |
2011-11-30 |
Seattle Genetics Inc |
Avristatinski konjugati in njihova uporaba za zdravljenje raka avtoimunske bolezni ali infekcijskebolezni
|
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
|
PL377769A1
(pl)
|
2002-10-09 |
2006-02-20 |
Rinat Neuroscience Corp. |
Sposób leczenia choroby Alzheimera z zastosowaniem przeciwciał skierowanych przeciw peptydowi beta amyloidu i ich kompozycje
|
|
AT413945B
(de)
|
2003-01-14 |
2006-07-15 |
Mattner Frank Dr |
Impfstoff für die alzheimer-krankheit
|
|
MXPA05008156A
(es)
|
2003-02-01 |
2005-09-30 |
Neuralab Ltd |
Inmunizacion activa para generar anticuerpos para beta-a soluble.
|
|
WO2004070388A1
(en)
|
2003-02-04 |
2004-08-19 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of scn2b protein for neurodegenerative diseases
|
|
DE602004027348D1
(de)
|
2003-02-10 |
2010-07-08 |
Applied Molecular Evolution |
Abeta-bindende moleküle
|
|
US8663650B2
(en)
|
2003-02-21 |
2014-03-04 |
Ac Immune Sa |
Methods and compositions comprising supramolecular constructs
|
|
US20040223971A1
(en)
*
|
2003-04-07 |
2004-11-11 |
Glycogenesys, Inc. |
Composition and uses of galectin antagonists
|
|
EP1617849B1
(en)
|
2003-04-07 |
2008-06-18 |
Prospect Therapeutics, Inc. |
Composition and uses of galectin antagonists
|
|
US7732162B2
(en)
|
2003-05-05 |
2010-06-08 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
|
|
ES2246178B1
(es)
|
2003-05-08 |
2007-03-01 |
Universidad De Zaragoza. |
Uso de anticuerpos para el tratamiento de enfermedades amiloideas.
|
|
US7276497B2
(en)
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
|
TWI374893B
(en)
|
2003-05-30 |
2012-10-21 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
WO2004111654A2
(en)
|
2003-06-06 |
2004-12-23 |
Ciphergen Biosystems, Inc. |
Serum biomarkers in ischaemic heart disease
|
|
JP4888876B2
(ja)
|
2003-06-13 |
2012-02-29 |
田平 武 |
アルツハイマー病の治療のための組換えアデノ随伴ウィルスベクター
|
|
US7384523B2
(en)
|
2003-07-10 |
2008-06-10 |
Radiometer Medical Aps |
Chloride ion selective membrane and sensor
|
|
EA008206B1
(ru)
|
2003-07-28 |
2007-04-27 |
Сиг Текнолоджи Лтд. |
Укупорочное устройство с колюще-режущим средством для многослойных упаковок или контейнеров, закрываемых плёнкой
|
|
TW200524910A
(en)
|
2003-08-08 |
2005-08-01 |
Schering Corp |
Cyclic amine BACE-1 inhibitors having a heterocyclic substituent
|
|
MXPA06001559A
(es)
|
2003-08-08 |
2006-05-15 |
Schering Corp |
Inhibidores de amina ciclica bace-1 que poseen una benzamida como sustituyente.
|
|
JPWO2005023286A1
(ja)
|
2003-09-05 |
2007-11-01 |
久光製薬株式会社 |
アルツハイマー病の予防及び／又は治療のための薬剤
|
|
AT413336B
(de)
|
2003-09-12 |
2006-02-15 |
Mattner Frank Dr |
Apherese-vorrichtung
|
|
EP1670943B1
(en)
|
2003-09-30 |
2013-11-13 |
Evotec International GmbH |
Diagnostic and therapeutic use of a sulfotransferase for alzheimer's disease
|
|
US7700823B2
(en)
|
2003-10-02 |
2010-04-20 |
Aventis Pharma S.A. |
Transgenic animals exhibiting major disorders related to Alzheimer's disease
|
|
EP1685159B1
(en)
*
|
2003-10-03 |
2012-08-01 |
Brigham & Women's Hospital |
Tim-3 polypeptides
|
|
GB0416511D0
(en)
|
2003-10-22 |
2004-08-25 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
WO2005071418A2
(en)
|
2003-10-29 |
2005-08-04 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of the human dax- 1 gene and protein for neurodegenerative diseases
|
|
ME01775B
(me)
|
2003-11-05 |
2011-02-28 |
Glycart Biotechnology Ag |
Cd20 antitijela sa povećanim afinitetom vezivanja za fc receptor i efektornom funkcijom
|
|
KR101438983B1
(ko)
|
2003-11-06 |
2014-09-05 |
시애틀 지네틱스, 인크. |
리간드에 접합될 수 있는 모노메틸발린 화합물
|
|
WO2005058352A2
(en)
|
2003-12-17 |
2005-06-30 |
Entelos, Inc. |
Treatment of rheumatoid arthritis with galectin-3 antagonists
|
|
ATE360630T1
(de)
|
2003-12-19 |
2007-05-15 |
Bristol Myers Squibb Co |
Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors
|
|
US7807157B2
(en)
|
2004-02-20 |
2010-10-05 |
Intellect Neurosciences Inc. |
Monoclonal antibodies and use thereof
|
|
US8060179B1
(en)
|
2006-11-16 |
2011-11-15 |
Scientific Nanomedicine, Inc. |
Biomagnetic detection and treatment of Alzheimer's Disease
|
|
US20070166718A1
(en)
|
2004-03-03 |
2007-07-19 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of mal2 gene and protein for neurodegenerative diseases
|
|
US20050239836A1
(en)
|
2004-03-09 |
2005-10-27 |
Varghese John |
Substituted hydroxyethylamine aspartyl protease inhibitors
|
|
JP5166861B2
(ja)
|
2004-03-09 |
2013-03-21 |
スピロゲン リミティッド |
ピロロベンゾジアゼピン
|
|
JPWO2005105998A1
(ja)
|
2004-04-27 |
2008-07-31 |
財団法人化学及血清療法研究所 |
ヒト抗アミロイドβペプチド抗体およびその抗体フラグメント
|
|
US7629443B2
(en)
|
2004-06-02 |
2009-12-08 |
New York Blood Center, Inc. |
Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus
|
|
DK1794313T3
(da)
|
2004-06-21 |
2013-07-22 |
Proteome Sciences Plc |
Fremgangsmåde til screeninger der anvender C-ABL, FYN og SYK i kombination med tau-protein
|
|
SE0401601D0
(sv)
|
2004-06-21 |
2004-06-21 |
Bioarctic Neuroscience Ab |
Protofibril specific antibodies and uses thereof
|
|
WO2006006198A1
(ja)
|
2004-07-07 |
2006-01-19 |
Mitsubishi Denki Kabushiki Kaisha |
電力算出装置、電力算出方法、耐タンパ性評価装置及び耐タンパ性評価方法
|
|
AT500483B1
(de)
|
2004-07-13 |
2006-01-15 |
Mattner Frank Dr |
Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung
|
|
AT413946B
(de)
|
2004-07-13 |
2006-07-15 |
Mattner Frank Dr |
Impfstoff gegen die alzheimer-krankheit
|
|
US7955812B2
(en)
|
2004-07-19 |
2011-06-07 |
The General Hospital Corporation |
Methods of diagnosing alzheimer's disease by detecting antibodies to cross-linked β-amyloid oligomers
|
|
US20060024667A1
(en)
|
2004-07-29 |
2006-02-02 |
Karen Manucharyan |
Compositions and methods for Alzheimer's disease
|
|
DE602005007245D1
(cg-RX-API-DMAC7.html)
|
2004-07-28 |
2008-07-10 |
Schering Corp |
|
|
WO2006017647A1
(en)
|
2004-08-03 |
2006-02-16 |
Transtech Pharma, Inc. |
Rage fusion proteins and methods of use
|
|
JP2008508893A
(ja)
|
2004-08-11 |
2008-03-27 |
エボテツク・ニユーロサイエンシーズ・ゲー・エム・ベー・ハー |
形質膜ａｔｐアーゼの診断及び治療への使用
|
|
JP4820757B2
(ja)
|
2004-08-11 |
2011-11-24 |
国立大学法人京都大学 |
抗体及びその利用
|
|
GB0421639D0
(en)
|
2004-09-29 |
2004-10-27 |
Proteome Sciences Plc |
Methods and compositions relating to alzheimer's disease
|
|
EP1797123B1
(en)
|
2004-10-08 |
2010-03-03 |
Université de Liège |
COMPLEMENTARY PEPTIDES FOR ß-AMYLOID 29-42 PEPTIDE
|
|
US9907485B2
(en)
|
2004-10-15 |
2018-03-06 |
Brainlab Ag |
Targeted immunization and plaque destruction against Alzheimer's disease
|
|
EP1812062B1
(en)
|
2004-10-25 |
2022-03-09 |
Merck Sharp & Dohme Corp. |
Anti-addl antibodies and uses thereof
|
|
EP1817336B1
(en)
|
2004-11-12 |
2019-01-09 |
Seattle Genetics, Inc. |
Auristatins having an aminobenzoic acid unit at the n terminus
|
|
TW200636066A
(en)
|
2004-12-15 |
2006-10-16 |
Elan Pharm Inc |
Humanized antibodies that recognize beta amyloid peptide
|
|
US8257740B1
(en)
|
2011-08-15 |
2012-09-04 |
Gp Medical, Inc. |
Pharmaceutical composition of nanoparticles
|
|
US20060257359A1
(en)
|
2005-02-28 |
2006-11-16 |
Cedric Francois |
Modifying macrophage phenotype for treatment of disease
|
|
US7632634B2
(en)
|
2005-04-15 |
2009-12-15 |
University Of Maryland Biotechnology Institute |
Method and assay for early diagnosis of prostate cancer
|
|
WO2006112553A2
(en)
|
2005-04-20 |
2006-10-26 |
Dnavec Corporation |
Highly safe intranasally administrable gene vaccines for treating alzheimer's disease
|
|
WO2006111759A1
(en)
|
2005-04-21 |
2006-10-26 |
Spirogen Limited |
Pyrrolobenzodiazepines
|
|
UY29504A1
(es)
|
2005-04-29 |
2006-10-31 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
|
|
MX2007013825A
(es)
|
2005-05-05 |
2008-01-18 |
Merck & Co Inc |
Composiciones de un conjugado peptidico y metodos para la prevencion y tratamiento de la enfermedad de alzheimer.
|
|
EP3530736A3
(en)
|
2005-05-09 |
2019-11-06 |
ONO Pharmaceutical Co., Ltd. |
Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
|
|
JP4929277B2
(ja)
|
2005-05-30 |
2012-05-09 |
武田薬品工業株式会社 |
神経変性疾患に対する診断上及び治療上の標的ｐｒｋｘタンパク質
|
|
JP2008545424A
(ja)
|
2005-06-01 |
2008-12-18 |
エボテツク・ニユーロサイエンシーズ・ゲー・エム・ベー・ハー |
神経変性疾患用の診断・治療標的ｓｌｃ３９ａ１２タンパク質
|
|
ATE489370T1
(de)
|
2005-06-14 |
2010-12-15 |
Schering Corp |
Herstellung und verwendung von verbindungen als aspartylproteasehemmer
|
|
US8722708B2
(en)
|
2005-06-14 |
2014-05-13 |
Merck Sharp & Dohme Inc. |
Substituted isoindolines as aspartyl protease inhibitors
|
|
EP1891241B1
(en)
|
2005-06-16 |
2011-01-12 |
EVOTEC Neurosciences GmbH |
Diagnostic and therapeutic target adarb2 proteins for neurodegenerative diseases
|
|
CA2611054C
(en)
|
2005-06-17 |
2017-05-09 |
National Research Council Of Canada |
Novel a.beta.-binding polypeptides and derivatives and uses thereof
|
|
DE102005029729A1
(de)
|
2005-06-24 |
2006-12-28 |
Röchling Automotive AG & Co. KG |
Verkleidungs- oder Gehäuseteil eines Fahrzeugs und Verfahren zu seiner Herstellung
|
|
WO2007008848A2
(en)
|
2005-07-07 |
2007-01-18 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus
|
|
US20070021282A1
(en)
|
2005-07-19 |
2007-01-25 |
Karp Shaun A |
Abdominal exercising and strength testing systems
|
|
WO2007022416A2
(en)
|
2005-08-18 |
2007-02-22 |
Ramot At Tel Aviv University Ltd. |
Single chain antibodies against beta-amyloid peptide
|
|
WO2007027559A2
(en)
|
2005-08-29 |
2007-03-08 |
Shashoua Victor E |
Neuroprotective and neurorestorative methods and compositions
|
|
WO2007062088A1
(en)
|
2005-11-22 |
2007-05-31 |
The Trustees Of The University Of Pennsylvania |
Antibody treatment of alzheimer's and related diseases
|
|
PL1976877T5
(pl)
|
2005-11-30 |
2017-09-29 |
Abbvie Inc |
Przeciwciała monoklonalne przeciwko białku amyloidu beta oraz ich zastosowania
|
|
WO2007064917A2
(en)
|
2005-11-30 |
2007-06-07 |
Abbott Laboratories |
Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
|
|
SI1813614T1
(sl)
|
2006-01-25 |
2012-01-31 |
Sanofi 174 |
Citotoksična sredstva, ki obsegajo nove tomajmicinske derivate
|
|
US7750116B1
(en)
|
2006-02-18 |
2010-07-06 |
Seattle Genetics, Inc. |
Antibody drug conjugate metabolites
|
|
KR20080103560A
(ko)
|
2006-02-22 |
2008-11-27 |
가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 |
항 아밀로이드-β-펩티드 항체 생산 유도용 펩티드 백신
|
|
AU2007219615B2
(en)
|
2006-03-03 |
2013-11-28 |
Promis Neurosciences Inc. |
Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
|
|
US20090311193A1
(en)
|
2006-03-23 |
2009-12-17 |
Invitrogen Corporation |
Methods and reagents for in vivo imaging of cancer cell lines
|
|
US8025878B2
(en)
|
2006-03-23 |
2011-09-27 |
Bioarctic Neuroscience Ab |
Protofibril selective antibodies and the use thereof
|
|
US8012936B2
(en)
|
2006-03-29 |
2011-09-06 |
New York University |
Tau fragments for immunotherapy
|
|
WO2009017467A1
(en)
|
2007-07-27 |
2009-02-05 |
Elan Pharma International Limited |
Treatment of amyloidogenic diseases
|
|
US8784810B2
(en)
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
|
WO2007129457A1
(ja)
|
2006-04-25 |
2007-11-15 |
The University Of Tokyo |
アルツハイマー病および癌の治療薬
|
|
JP2009538924A
(ja)
|
2006-06-01 |
2009-11-12 |
エラン ファーマシューティカルズ，インコーポレイテッド |
Ａｐｐの神経活性断片
|
|
WO2008004346A1
(fr)
|
2006-07-06 |
2008-01-10 |
Nec Corporation |
Procédé et dispositif de conception d'une hiérarchie de circuit intégré semi-conducteur
|
|
WO2008022349A2
(en)
|
2006-08-18 |
2008-02-21 |
Armagen Technologies, Inc. |
Agents for blood-brain barrier delivery
|
|
JP5207469B2
(ja)
|
2006-09-06 |
2013-06-12 |
国立大学法人鳥取大学 |
アルツハイマーの診断キット、診断マーカー及び病態指標の検出方法
|
|
WO2008036717A2
(en)
*
|
2006-09-19 |
2008-03-27 |
Emory University |
Use of soluble galectin-3 (gal-3) for cancer treatment
|
|
WO2008085564A2
(en)
|
2006-09-20 |
2008-07-17 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods involving truncated recombinant seven g-protein coupled receptors
|
|
US8420613B2
(en)
|
2006-11-15 |
2013-04-16 |
The J. David Gladstone Institutes |
Methods and compositions for reducing amyloid beta levels
|
|
CA2668693A1
(en)
*
|
2006-11-15 |
2008-05-22 |
David E. Anderson |
Therapeutic uses of tim-3 modulators
|
|
GB0624500D0
(en)
|
2006-12-07 |
2007-01-17 |
Istituto Superiore Di Sanito |
A novel passive vaccine for candida infections
|
|
WO2008073817A2
(en)
|
2006-12-08 |
2008-06-19 |
Dana-Farber Cancer Institute, Inc. |
Muc1 and galectin-3
|
|
HRP20170530T1
(hr)
|
2006-12-21 |
2017-06-02 |
H. Lundbeck A/S |
Modulacija aktivnosti proneutrofina
|
|
HRP20140049T1
(hr)
|
2007-01-05 |
2014-02-28 |
University Of Zürich |
Anti beta-amiloid antitijela i njihova upotreba
|
|
CN103360495B
(zh)
|
2007-01-09 |
2016-06-08 |
比奥根Ma公司 |
Sp35抗体及其用途
|
|
WO2008084402A2
(en)
|
2007-01-11 |
2008-07-17 |
Philipps-Universitaet Marburg |
Diagnosis and treatment of alzheimer's and other neurodementing diseases
|
|
LT2842967T
(lt)
|
2007-01-18 |
2017-02-27 |
Eli Lilly And Company |
Beta amiloido pegilintas fab
|
|
WO2008112559A1
(en)
|
2007-03-09 |
2008-09-18 |
Regents Of The University Of California |
Suppression of galectin-3 for treating an inflammatory condition
|
|
EP2149584B1
(en)
|
2007-04-20 |
2017-12-13 |
The Chemo-Sero-Therapeutic Research Institute |
Method for enhancing immune response with peptide
|
|
WO2008133772A1
(en)
|
2007-04-26 |
2008-11-06 |
Ludwig Institute For Cancer Research |
Method for modulating activity of t lymphocytes
|
|
WO2008134034A1
(en)
|
2007-04-26 |
2008-11-06 |
Yale University |
Prion protein as a receptor for amyloid-beta oligomers
|
|
EP2152309B1
(en)
|
2007-05-14 |
2013-07-10 |
Medtronic, Inc. |
Methods and device to neutralize soluble toxic agents in the brain
|
|
CN101754960A
(zh)
|
2007-07-05 |
2010-06-23 |
先灵公司 |
四氢吡喃并色烯γ-分泌酶抑制剂
|
|
CN101970445A
(zh)
|
2007-07-17 |
2011-02-09 |
先灵公司 |
苯磺酰基-色满、硫代色满、四氢萘和相关γ分泌酶抑制剂
|
|
ES2435779T3
(es)
|
2007-07-19 |
2013-12-23 |
Sanofi |
Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico
|
|
US8993833B2
(en)
|
2007-08-14 |
2015-03-31 |
Duke University |
Model of Alzheimer's Disease
|
|
JP2010536907A
(ja)
|
2007-08-31 |
2010-12-02 |
ニューリミューン セラピューティクス エイジー |
患者にアミロイドーシスおよびタンパク質凝集性障害における特異的免疫応答をもたらす方法
|
|
EP2200990A1
(en)
|
2007-09-06 |
2010-06-30 |
Schering Corporation |
Gamma secretase modulators
|
|
EP2527369A3
(en)
|
2007-09-13 |
2012-12-19 |
University Of Zurich Prorektorat Forschung |
Monoclonal amyloid beta (abeta)-specific antibody and uses thereof
|
|
JP5185946B2
(ja)
|
2007-10-29 |
2013-04-17 |
Ｔａｏヘルスライフファーマ株式会社 |
抗体及びその利用
|
|
UA103602C2
(ru)
|
2007-10-29 |
2013-11-11 |
Енсерм (Енстітю Насьональ Де Ля Санте Е Де Ля Решер Медікалє) |
АНТИТЕЛО, СПЕЦИФИЧНОЕ К β-АМИЛОИДНЫМ ПЕПТИДАМ, И ЕГО ПРИМЕНЕНИЕ В КАЧЕСТВЕ ДИАГНОСТИЧЕСКОГО ИЛИ ЛЕКАРСТВЕННОГО СРЕДСТВА
|
|
ES2445446T3
(es)
|
2007-11-01 |
2014-03-03 |
F. Hoffmann-La Roche Ag |
Animales no humanos cuatro veces transgénicos
|
|
WO2009061699A1
(en)
|
2007-11-05 |
2009-05-14 |
Schering Corporation |
Gamma secretase modulators
|
|
KR101397554B1
(ko)
|
2007-11-09 |
2014-05-21 |
재단법인서울대학교산학협력재단 |
치매(알츠하이머 병)의 진단, 예방, 치료제 및 이들의스크리닝 방법
|
|
MX2010005282A
(es)
|
2007-11-13 |
2010-08-31 |
Teva Pharma |
Anticuerpos humanizados contra tl1a.
|
|
MY158903A
(en)
|
2007-11-16 |
2016-11-30 |
Univ Rockefeller |
Antibodies specific for the protofibril form of beta-amyloid protein
|
|
US8349579B2
(en)
|
2007-12-13 |
2013-01-08 |
Wayne State University |
Galectin-3 cleavage as a marker for matrix metalloproteinase activity in cancer
|
|
WO2009087689A2
(en)
|
2008-01-07 |
2009-07-16 |
Council Of Scientific & Industrial Research |
Novel primers for identification of astrocytoma, it's grades and glioblastoma prognosis
|
|
ITNA20080006A1
(it)
|
2008-01-28 |
2009-07-29 |
Consiglio Nazionale Ricerche |
Proteine chimeriche capaci di formare particelle virus-like, che contengono sequenze peptidiche del beta-amiloide e la componente e2 della alfachetoacido deidrogenasi di "geobacillus stearothermophilus", utili per l'induzione di una risposta anticorp
|
|
AU2009211635B2
(en)
|
2008-02-08 |
2014-06-26 |
National Center For Geriatrics And Gerontology |
Antibody capable of binding specifically to Abeta-oligomer, and use thereof
|
|
CA2716521A1
(en)
|
2008-02-29 |
2009-09-11 |
Baxter Healthcare S.A. |
Anti-amyloid .beta. activity of intravenous immunoglobulin (ivig) in vitro
|
|
FR2929292A1
(fr)
|
2008-03-28 |
2009-10-02 |
Exonhit Therapeutics S A Sa |
Procede et methodes de diagnostic de la maladie d'alzheimer
|
|
US9908943B2
(en)
|
2008-04-03 |
2018-03-06 |
Vib Vzw |
Single domain antibodies capable of modulating BACE activity
|
|
EP2262526B1
(en)
|
2008-04-14 |
2015-12-02 |
Alzinova AB |
Stable amyloid beta monomers and oligomers
|
|
AR071698A1
(es)
|
2008-05-09 |
2010-07-07 |
Abbott Gmbh & Co Kg |
Anticuerpos contra el receptor de productos finales de glicosilacion avanzada (rage) y usos de los mismos
|
|
EP2299812B1
(en)
|
2008-05-27 |
2017-07-12 |
Yale University |
Targeting tgf-beta as a therapy for alzheimer's disease
|
|
US8969023B2
(en)
|
2008-06-10 |
2015-03-03 |
Eleanore Bennett Charitable Trust #2 |
Methods and compositions for treating alzheimer's disease
|
|
EP2303926A1
(en)
|
2008-06-20 |
2011-04-06 |
Oklahoma Medical Research Foundation |
Immunogenic memapsin 2 -secretase peptides and methods of use
|
|
EP2303001A4
(en)
|
2008-06-20 |
2016-07-13 |
Janssen Biotech Inc |
METHOD FOR VERIFYING THE EFFECTIVENESS OF TREATMENT OF NEUROLOGICAL ILLNESSES
|
|
ES2687259T5
(es)
|
2008-06-25 |
2022-10-14 |
Novartis Ag |
Anticuerpos estables y solubles que inhiben TNF
|
|
AU2009266552B2
(en)
|
2008-07-01 |
2014-01-23 |
De Staat Der Nederlanden, Vert. Door De Minister Van Vws |
Vaccine against amyloid folding intermediate
|
|
CA2730048A1
(en)
|
2008-07-08 |
2010-01-14 |
Merck Sharp & Dohme Corp. |
Vaccine for the treatment of alzheimer's disease
|
|
NO2824100T3
(cg-RX-API-DMAC7.html)
|
2008-07-08 |
2018-07-21 |
|
|
|
GB0813432D0
(en)
|
2008-07-22 |
2008-08-27 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
KR20160127181A
(ko)
|
2008-08-12 |
2016-11-02 |
진판델 파마슈티컬스 인코포레이티드 |
질환 위험 인자의 식별 방법
|
|
US8283322B2
(en)
|
2008-08-15 |
2012-10-09 |
Orthopeutics, Lp |
Formulations for nonsurgical exogenous crosslink therapy
|
|
JP2012504650A
(ja)
|
2008-10-02 |
2012-02-23 |
セルタクシス，インコーポレイテッド |
免疫細胞の負の走化性の調節方法
|
|
US20100143954A1
(en)
*
|
2008-10-29 |
2010-06-10 |
Bg Medicine, Inc. |
Galectin-3 Immunoassay
|
|
WO2010062706A2
(en)
|
2008-10-30 |
2010-06-03 |
Caris Mpi, Inc. |
Methods for assessing rna patterns
|
|
CA2742486A1
(en)
|
2008-11-13 |
2010-05-20 |
Schering Corporation |
Gamma secretase modulators
|
|
WO2010056722A1
(en)
|
2008-11-13 |
2010-05-20 |
Schering Corporation |
Gamma secretase modulators
|
|
DE102008037564A1
(de)
|
2008-11-19 |
2010-05-20 |
Forschungszentrum Jülich GmbH |
Zusammensetzung zur Herstellung von anti-Amyloid beta-Peptid-Antikörpern mit D-Peptiden
|
|
US8912145B2
(en)
|
2008-11-28 |
2014-12-16 |
Hokko Chemical Industry Co., Ltd. |
Vaccine composition for prophylaxis and/or therapy of Alzheimer's disease
|
|
EP2373338B1
(en)
*
|
2008-12-03 |
2017-02-15 |
The Johns Hopkins University |
Annexina2 as immunological target
|
|
WO2010070043A1
(en)
|
2008-12-19 |
2010-06-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Biomarkers for the diagnosis of renal allograft and kidney status
|
|
JP2012513399A
(ja)
|
2008-12-22 |
2012-06-14 |
シェーリング コーポレイション |
γ−セクレターゼ調節剤
|
|
US20100196882A1
(en)
*
|
2009-02-04 |
2010-08-05 |
Avraham Raz |
GALECTIN-3 nsSNP MARKER FOR CANCER
|
|
CN105175434A
(zh)
|
2009-02-05 |
2015-12-23 |
伊缪诺金公司 |
新型苯并二氮杂*衍生物
|
|
FR2942476B1
(fr)
|
2009-02-20 |
2013-03-15 |
Commissariat Energie Atomique |
Composes de type pyridocarbazole et leurs applications
|
|
HUE055739T2
(hu)
|
2009-03-18 |
2021-12-28 |
Ac Immune Sa |
Eljárás terápiás alkalmazásra
|
|
US9173928B2
(en)
|
2009-03-26 |
2015-11-03 |
Yoh Matsumoto |
DNA vaccine for Alzheimer's disease
|
|
JP2010268789A
(ja)
|
2009-04-24 |
2010-12-02 |
Kumamoto Univ |
細胞医薬の製造方法
|
|
FR2945538B1
(fr)
|
2009-05-12 |
2014-12-26 |
Sanofi Aventis |
Anticorps humanises specifiques de la forme protofibrillaire du peptide beta-amyloide.
|
|
EP2258398A1
(en)
|
2009-05-26 |
2010-12-08 |
Araclón Biotech, S. L. |
Albumin-amyloid peptide conjugates and uses thereof
|
|
CA2765099A1
(en)
|
2009-06-10 |
2010-12-16 |
New York University |
Phosphorylated tau peptide for use in the treatment of tauopathy
|
|
EP3118222A1
(en)
|
2009-06-15 |
2017-01-18 |
Vib Vzw |
Bace1 inhibitory antibodies
|
|
WO2010147969A2
(en)
|
2009-06-16 |
2010-12-23 |
Schering Corporation |
Gamma secretase modulators
|
|
WO2011001366A1
(en)
|
2009-06-29 |
2011-01-06 |
Bioartic Neuroscience Ab |
N-terminal truncated amyloid beta protofibrils/ oligomers for use in therapeutic and diagnostic methods for alzheimer's disease
|
|
EP2273273A1
(en)
|
2009-07-11 |
2011-01-12 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Inhibitors of the nitration of amyloid ß peptides and their uses in the diagnosis and treatment of alzheimer's disease
|
|
CN102439727B
(zh)
|
2009-07-15 |
2015-05-20 |
富士电机株式会社 |
超结半导体器件
|
|
WO2011016238A1
(en)
|
2009-08-06 |
2011-02-10 |
Immunas Pharma, Inc. |
Antibodies that specifically bind to a beta oligomers and use thereof
|
|
AU2010279892B8
(en)
|
2009-08-07 |
2014-09-25 |
Oncotherapy Science, Inc. |
Humanized anti-amyloid-b oligomer antibody
|
|
KR20120104167A
(ko)
|
2009-08-25 |
2012-09-20 |
비쥐 메디신, 인코포레이티드 |
갈렉틴―3 및 심장 재동기화 요법
|
|
US8778343B2
(en)
|
2009-08-28 |
2014-07-15 |
The Board Of Regents Of The University Of Texas System |
Antibodies that bind tau oligomers
|
|
US8617549B2
(en)
|
2009-09-11 |
2013-12-31 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University |
Bispecific nanobodies as a therapeutic for alzheimer's disease
|
|
DE102009043750A1
(de)
|
2009-09-30 |
2011-08-04 |
Carl Zeiss Meditec AG, 07745 |
Verfahren und Vorrichtung zur Detektion von Ablagerungen im Auge
|
|
JPWO2011045945A1
(ja)
|
2009-10-16 |
2013-03-04 |
国立大学法人京都大学 |
アミロイドβのターン構造を認識する抗体
|
|
US9757398B2
(en)
|
2010-02-20 |
2017-09-12 |
Euroespes Biotecnnologia, S.L. |
Prevention and treatment of alzheimer's disease by amyloid beta peptide and sphin-gosine-1-phosphate
|
|
MX341536B
(es)
|
2010-03-03 |
2016-08-24 |
The Univ Of British Columbia * |
Epitopo y anticuerpos beta amiloide de oligomero especifico.
|
|
WO2011119842A1
(en)
|
2010-03-25 |
2011-09-29 |
The J. David Gladstone Institutes |
Compositions and methods for treating neurological disorders
|
|
SG184820A1
(en)
|
2010-04-13 |
2012-11-29 |
Baxter Int |
Use of ventricular enlargement rate in intravenous immunoglobulin treatment of alzheimer's disease
|
|
MX368648B
(es)
|
2010-04-15 |
2019-10-09 |
Seattle Genetics Inc |
Pirrolobenzodiazepinas usadas para tratar enfermedades proliferativas.
|
|
BR112012026801B8
(pt)
|
2010-04-15 |
2021-05-25 |
Medimmune Ltd |
conjugados de pirrolobenzodiazepina direcionados, composição farmacêutica, uso dos mesmos para tratamento de uma doença proliferativa ou autoimune e ligante de medicamento
|
|
US20130065258A1
(en)
|
2010-05-25 |
2013-03-14 |
Makoto Watanabe |
Colorectal cancer marker galectin, method for analyzing galectin concentration in blood sample, and kit for detecting colorectal cancer marker galectin
|
|
AU2011263642B2
(en)
|
2010-06-11 |
2014-09-04 |
Isarna Therapeutics Gmbh |
Method for selective oligonucleotide modification
|
|
US20130115227A1
(en)
|
2010-07-14 |
2013-05-09 |
Renee C. Gaspar |
Anti-addl monoclonal antibody and uses thereof
|
|
US10420923B1
(en)
|
2010-08-10 |
2019-09-24 |
Amiram Katz |
Method and device for intrathecal administering of immunoglobulin
|
|
PL3042917T3
(pl)
|
2010-08-12 |
2018-07-31 |
Eli Lilly And Company |
Przeciwciała przeciwko peptydowi beta amyloidu N3pGlu i ich zastosowanie
|
|
US8877207B2
(en)
|
2010-09-17 |
2014-11-04 |
University Of Central Florida Research Foundation, Inc. |
Nanoparticles of cerium oxide targeted to an amyloid-beta antigen of Alzheimer's disease and associated methods
|
|
MX2013005046A
(es)
|
2010-11-03 |
2013-12-12 |
Immunogen Inc |
Agentes citotoxicos que comprenden nuevos derivados de ansamitocina.
|
|
US10117895B2
(en)
|
2010-11-17 |
2018-11-06 |
Ben-Gurion University Of The Negev Research And Development Authority |
T-cell therapy to neurodegenerative diseases
|
|
DK2646470T3
(en)
|
2010-11-30 |
2017-05-08 |
Hoffmann La Roche |
ANTI-TRANSFERRIN RECEPTOR ANTIBODIES WITH LOW AFFINITY AND ITS USE FOR TRANSPORTING THERAPEUTIC SCFV OVER THE BLOOD-BRAIN BARRIER
|
|
EP2660600B1
(en)
|
2010-12-28 |
2018-08-08 |
Sumitomo Dainippon Pharma Co., Ltd. |
Diagnostic drug and diagnostic method for alzheimer's disease
|
|
CA2826286C
(en)
|
2011-01-31 |
2021-09-21 |
Intellect Neurosciences Inc. |
Treatment of tauopathies
|
|
CN106940375B
(zh)
|
2011-03-17 |
2019-03-08 |
重症监护诊断股份有限公司 |
预测不良临床结果的风险的方法
|
|
EP2508212A1
(en)
|
2011-04-05 |
2012-10-10 |
Universitätsklinikum Freiburg |
Biocompatible and biodegradable gradient layer system for regenerative medicine and for tissue support
|
|
WO2012136552A1
(en)
|
2011-04-08 |
2012-10-11 |
H. Lundbeck A/S |
ANTIBODIES SPECIFIC TO PYROGLUTAMATED Αβ
|
|
KR101589135B1
(ko)
|
2011-04-20 |
2016-01-29 |
주식회사 셀앤바이오 |
인간화 항-ｅｍａｐｉｉ 항체 및 이의 용도
|
|
AU2012250496A1
(en)
|
2011-05-03 |
2013-11-28 |
Commonwealth Scientific And Industrial Research Organisation |
Method for detection of a neurological disease
|
|
GB201108490D0
(en)
|
2011-05-18 |
2011-07-06 |
Ucl Business Plc |
Methods and uses
|
|
WO2012159027A2
(en)
|
2011-05-19 |
2012-11-22 |
President And Fellows Of Harvard College |
Osw-1 analogs and conjugates, and uses thereof
|
|
AR086543A1
(es)
*
|
2011-05-25 |
2014-01-08 |
Bg Medicine Inc |
Inhibidores de galectina-3 y metodos de uso de los mismos, composicion farmaceutica
|
|
WO2012177837A2
(en)
|
2011-06-21 |
2012-12-27 |
Immunogen, Inc. |
Novel maytansinoid derivatives with peptide linker and conjugates thereof
|
|
WO2013008402A1
(ja)
|
2011-07-08 |
2013-01-17 |
シャープ株式会社 |
薄膜トランジスタ基板及びそれを備えた表示装置
|
|
GB201113482D0
(en)
|
2011-08-04 |
2011-09-21 |
Univ Liverpool |
Assay
|
|
EP3321286B1
(en)
|
2011-08-23 |
2021-01-06 |
Roche Glycart AG |
Bispecific t cell activating antigen binding molecules
|
|
US9365647B2
(en)
|
2011-09-19 |
2016-06-14 |
University Of The Witwatersrand, Johannesburg |
Compounds for use in the treatment of Alzheimer's disease
|
|
AU2012311234B2
(en)
|
2011-09-19 |
2017-09-28 |
Axon Neuroscience Se |
Protein-based therapy and diagnosis of tau-mediated pathology in Alzheimer's disease
|
|
EP2748337B1
(en)
|
2011-09-23 |
2019-08-07 |
Siemens Healthcare Diagnostics Inc. |
Cell response assay for cancer and methods of producing and using same
|
|
JP6393617B2
(ja)
|
2011-10-14 |
2018-09-19 |
シアトル ジェネティクス，インコーポレーテッド |
ピロロベンゾジアゼピンおよび標的コンジュゲート
|
|
ES2669068T3
(es)
|
2011-12-08 |
2018-05-23 |
Eliaz Therapeutics, Inc |
Reducción de niveles de galectina-3 mediante plasmaféresis
|
|
US9549953B2
(en)
|
2011-12-08 |
2017-01-24 |
Eliaz Therapeutics, Inc. |
Galectin-3 plasmapheresis therapy
|
|
US8764695B2
(en)
|
2012-09-28 |
2014-07-01 |
Isaac Eliaz |
Reduction of galectin-3 levels by plasmapheresis
|
|
US20140370521A1
(en)
|
2011-12-15 |
2014-12-18 |
The USA , as Represented by the Secretary, Department of Health & Human Services |
Identification of two novel biomarkers for niemann-pick disease type c
|
|
US20130164217A1
(en)
|
2011-12-21 |
2013-06-27 |
Meso Scale Technologies, Llc |
Method of diagnosing, preventing and/or treating dementia & related disorders
|
|
JP5828461B2
(ja)
|
2011-12-29 |
2015-12-09 |
Ｔａｏヘルスライフファーマ株式会社 |
アミロスフェロイドが結合して成熟神経細胞死を誘発する標的分子、アミロスフェロイドが誘導する神経細胞死を抑制する方法及び物質、及びそれらの利用
|
|
EP2802602B1
(en)
|
2012-01-11 |
2019-03-27 |
Arizona Board of Regents, a Body Corporate of the State of Arizona acting for and on behalf of Arizona State University |
Bispecific antibody fragments for neurological disease proteins and methods of use
|
|
BR112014019431A8
(pt)
|
2012-02-07 |
2017-07-11 |
Global Bio Therapeutics Usa Inc |
Método compartimentalizado de distribuição de ácido nucleico e composições e usos desses
|
|
WO2013120497A1
(en)
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
|
|
ES2617853T3
(es)
|
2012-02-27 |
2017-06-20 |
Universitat De Barcelona |
Compuestos resistentes a proteasas útiles como transportadores a través de la barrera hematoencefálica y construcciones de transportador-carga
|
|
ITRM20120383A1
(it)
|
2012-03-20 |
2013-09-21 |
Uni Degli Studi Di Milano B Icocca |
Metodo e kit per la rivelazione di anticorpi.
|
|
CA2907909A1
(en)
|
2012-03-26 |
2013-10-03 |
Neuroquest Ltd. |
Cellular markers for diagnosis of alzheimer's disease and for alzheimer's disease progression
|
|
WO2013152313A1
(en)
|
2012-04-05 |
2013-10-10 |
The Regents Of The University Of California |
Compositions and methods for treating cancer and diseases and conditions responsive to growth factor inhibition
|
|
WO2013151762A1
(en)
|
2012-04-05 |
2013-10-10 |
Ac Immune S.A. |
Humanized tau antibody
|
|
WO2013169890A1
(en)
|
2012-05-08 |
2013-11-14 |
Bg Medicine, Inc. |
Systems and methods for assessing disease risk, status, and prognosis
|
|
US9617332B2
(en)
|
2012-05-10 |
2017-04-11 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin |
Conformational-specific antibodies against A[β] oligomers
|
|
ES2887208T3
(es)
|
2012-05-15 |
2021-12-22 |
Concortis Biosystems Corp |
Conjugados de fármacos y usos de los mismos
|
|
US9682143B2
(en)
|
2012-08-14 |
2017-06-20 |
Ibc Pharmaceuticals, Inc. |
Combination therapy for inducing immune response to disease
|
|
FR2994803B1
(fr)
|
2012-08-30 |
2016-02-26 |
Oreal |
Modulation de la forme des fibres keratiniques
|
|
EP2890788A1
(en)
|
2012-08-31 |
2015-07-08 |
The General Hospital Corporation |
Biotin complexes for treatment and diagnosis of alzheimer's disease
|
|
EP3919079A1
(en)
|
2012-09-07 |
2021-12-08 |
Genentech, Inc. |
Combination therapy of a type ii anti-cd20 antibody with a selective bcl-2 inhibitor
|
|
KR102207767B1
(ko)
*
|
2012-09-17 |
2021-01-26 |
갈렉틴 테라퓨틱스, 인크. |
암 치료에서의 특이적 면역요법을 강화하는 방법
|
|
EP4029937A1
(en)
|
2012-10-04 |
2022-07-20 |
Research Development Foundation |
Serine protease molecules and therapies
|
|
RU2651486C2
(ru)
|
2012-10-15 |
2018-04-19 |
Медиммьюн Лимитед |
Антитела к бета-амилоиду
|
|
CA2892490A1
(en)
|
2012-11-26 |
2014-05-30 |
Caris Science, Inc. |
Biomarker compositions and methods
|
|
US9066928B1
(en)
|
2012-12-04 |
2015-06-30 |
University Of Kentucky Research Foundation |
Method, composition, and kit useful for treatment of alzheimer's disease
|
|
RU2015129800A
(ru)
|
2012-12-21 |
2017-01-30 |
Биоэллаенс К. В. |
Гидрофильные саморазрушающиеся линкеры и их конъюгаты
|
|
US9433665B2
(en)
|
2013-01-11 |
2016-09-06 |
Cyvax, Inc. |
Vaccines for protection from and treatment of alzheimer's disease
|
|
JP6372040B2
(ja)
|
2013-02-06 |
2018-08-15 |
公立大学法人横浜市立大学 |
抗セマフォリン３ａ抗体、並びにこれを用いたアルツハイマー病及び免疫・炎症性疾患の治療
|
|
WO2014131694A1
(en)
|
2013-02-26 |
2014-09-04 |
Roche Glycart Ag |
Bispecific t cell activating antigen binding molecules
|
|
SI2961426T1
(sl)
|
2013-02-26 |
2020-01-31 |
Baxalta GmbH |
Zdravljanje motenj centralnega živčnega sistema z intranazalnim dajanjem imunoglobulina G
|
|
AU2014249107C1
(en)
|
2013-03-12 |
2018-07-19 |
Molecular Templates, Inc. |
CD20-binding immunotoxins for inducing cellular internalization and methods using same
|
|
AR096287A1
(es)
|
2013-03-13 |
2015-12-23 |
Spirogen Sàrl |
Pirrolobenzodiacepinas y conjugados
|
|
EP2777714A1
(en)
|
2013-03-15 |
2014-09-17 |
NBE-Therapeutics LLC |
Method of producing an immunoligand/payload conjugate by means of a sequence-specific transpeptidase enzyme
|
|
US9879076B2
(en)
|
2013-03-15 |
2018-01-30 |
Ramot At Tel Aviv University Ltd. |
Methods and compositions with immune therapy for treatment of dementia
|
|
AU2013203043B2
(en)
|
2013-03-15 |
2016-10-06 |
Takeda Pharmaceutical Company Limited |
Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
|
|
EP2968548B1
(en)
|
2013-03-15 |
2020-09-09 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the generation and use of conformation-specific antibodies
|
|
CA2918194C
(en)
|
2013-03-27 |
2022-12-06 |
The General Hospital Corporation |
Methods and agents for treating alzheimer's disease
|
|
WO2014182631A1
(en)
|
2013-05-06 |
2014-11-13 |
Baxter International Inc. |
Treatment of alzheimer's disease subpopulations with pooled immunoglobulin g
|
|
JP2016520615A
(ja)
|
2013-05-31 |
2016-07-14 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
アルツハイマー病を処置するためのｉｌ−１アンタゴニストを使用する方法
|
|
WO2014206899A1
(en)
|
2013-06-25 |
2014-12-31 |
Icm (Institut Du Cerveau Et De La Moelle Épinière) |
Boosting treg cells for treating alzheimer disease and related disorders
|
|
WO2015031084A1
(en)
|
2013-08-28 |
2015-03-05 |
Jianfeng Cai |
Methods of synthesizing y-aapeptides, y-aapeptide building blocks, y-aapeptide libraries, and y-aapeptide inhibitors of ab40 aggregates
|
|
WO2015038426A1
(en)
|
2013-09-13 |
2015-03-19 |
Asana Biosciences, Llc |
Self-immolative linkers containing mandelic acid derivatives, drug-ligand conjugates for targeted therapies and uses thereof
|
|
EP3043802B1
(en)
|
2013-09-13 |
2018-04-18 |
Merck Sharp & Dohme Corp. |
C5-spiro iminothiazine dioxides as bace inhibitors, compositions, and their use
|
|
WO2015051850A1
(en)
|
2013-10-11 |
2015-04-16 |
Universität Für Bodenkultur Wien |
Compositions containing galectin-3 modulators for the treatment of bone disorders
|
|
RU2016134258A
(ru)
|
2013-10-15 |
2018-02-28 |
Сорренто Терапьютикс Инк. |
Конъюгат лекарственного средства с направляющей молекулой и двумя различными лекарственными средствами
|
|
GB201319761D0
(en)
|
2013-11-08 |
2013-12-25 |
Nordic Bioscience As |
Biomarkers of disease progression
|
|
RS60031B1
(sr)
|
2013-12-20 |
2020-04-30 |
Hoffmann La Roche |
Humanizovana anti-tau(ps422) antitela i načini upotrebe
|
|
US9989541B2
(en)
|
2013-12-27 |
2018-06-05 |
Dignity Health |
Diagnosing and treating alzheimer's disease
|
|
US10272083B2
(en)
|
2014-01-21 |
2019-04-30 |
Acerta Pharma B.V. |
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor
|
|
MX382229B
(es)
|
2014-01-27 |
2025-03-13 |
Molecular Templates Inc |
Polipéptidos que administran epítopos de cmh de clase i.
|
|
US20210138076A2
(en)
|
2014-01-27 |
2021-05-13 |
Molecular Templates, Inc. |
Cell-targeting molecules comprising shiga toxin a subunit effectors and cd8+ t-cell epitopes
|
|
US20160177284A1
(en)
|
2014-01-27 |
2016-06-23 |
Molecular Templates, Inc. |
Cell-targeted molecules comprising amino-terminus proximal or amino-terminal shiga toxin a subunit effector regions
|
|
JOP20200096A1
(ar)
|
2014-01-31 |
2017-06-16 |
Children’S Medical Center Corp |
جزيئات جسم مضاد لـ tim-3 واستخداماتها
|
|
US10421958B2
(en)
|
2014-02-05 |
2019-09-24 |
Molecular Templates, Inc. |
Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity
|
|
ES2873248T3
(es)
|
2014-02-08 |
2021-11-03 |
Hoffmann La Roche |
Métodos para tratar la enfermedad de Alzheimer
|
|
CA2942320A1
(en)
*
|
2014-03-10 |
2015-09-17 |
La Jolla Pharmaceutical Company |
Compositions and methods for treating kidney disorders
|
|
HUE054529T2
(hu)
|
2014-03-11 |
2021-09-28 |
Molecular Templates Inc |
Amino-terminális proximális Shiga toxin A alegység effektor régiókat és sejtcélzó immunglobulin-típusú kötõrégiókat tartalmazó proteinek, amelyek képesek CD38 specifikus kötésére
|
|
CA2940252C
(en)
|
2014-03-11 |
2022-10-18 |
Molecular Templates, Inc. |
Proteins comprising binding regions, shiga toxin a subunit effector regions, and carboxy-terminal, endoplasmic reticulum localization signal motifs
|
|
BR112016020919A2
(pt)
|
2014-03-12 |
2018-01-23 |
Yeda Res & Dev |
redução dos níveis ou da atividade sistêmica de células t regulatórias para o tratamento de doença e lesão do snc
|
|
KR20180078347A
(ko)
|
2014-04-10 |
2018-07-09 |
화이자 인코포레이티드 |
2-아미노-6-메틸-4,4a,5,6-테트라히드로피라노[3,4-d][1,3]티아진-8a(8H)-일-1,3-티아졸-4-일 아미드
|
|
EP3133394B1
(en)
|
2014-04-16 |
2022-06-01 |
Kyowa Kirin Co., Ltd. |
Method for measuring toxicity of human csf
|
|
US9737505B2
(en)
|
2014-04-29 |
2017-08-22 |
Glaxosmithkline Intellectual Property Development Limited |
Prodrug of 1,1′-(1,6-dioxo-1,6-hexanediyl)bis-D-proline
|
|
US11219627B2
(en)
|
2014-05-16 |
2022-01-11 |
Synaptec Development Llc |
Clearance of amyloid beta
|
|
KR102496206B1
(ko)
|
2014-06-11 |
2023-02-06 |
몰레큘러 템플레이츠, 인코퍼레이션. |
프로테아제-절단 저항성의 시가 독소 a 서브유닛 작동체 폴리펩티드 및 이를 포함하는 세포-표적화 분자
|
|
US20150377905A1
(en)
|
2014-06-25 |
2015-12-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for diagnosis of kawasaki disease
|
|
AR100978A1
(es)
|
2014-06-26 |
2016-11-16 |
Hoffmann La Roche |
LANZADERAS CEREBRALES DE ANTICUERPO HUMANIZADO ANTI-Tau(pS422) Y USOS DE LAS MISMAS
|
|
EP3161671A4
(en)
|
2014-06-30 |
2017-06-28 |
Microsoft Technology Licensing, LLC |
Managing data with flexible schema
|
|
WO2016004093A2
(en)
|
2014-07-01 |
2016-01-07 |
Stealth Biotherapeutics Corp |
Therapeutic compositions including galectin-3 inhibitors and uses thereof
|
|
US10132818B2
(en)
|
2014-07-08 |
2018-11-20 |
New York University |
Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy
|
|
CN112390881B
(zh)
|
2014-07-10 |
2025-02-21 |
生命北极神经科学公司 |
改进的Aβ初原纤维结合抗体
|
|
PL3177643T3
(pl)
|
2014-08-04 |
2019-09-30 |
F.Hoffmann-La Roche Ag |
Dwuswoiste cząsteczki wiążące antygen aktywujące komórki T
|
|
ES2900184T3
(es)
|
2014-08-11 |
2022-03-16 |
Acerta Pharma Bv |
Combinaciones terapéuticas de un inhibidor de BTK y un inhibidor de BCL-2
|
|
JP6736002B2
(ja)
|
2014-08-14 |
2020-08-05 |
国立大学法人広島大学 |
早産および／または低体重児出産のリスク判定を行うための方法およびキット
|
|
JO3663B1
(ar)
|
2014-08-19 |
2020-08-27 |
Merck Sharp & Dohme |
الأجسام المضادة لمضاد lag3 وأجزاء ربط الأنتيجين
|
|
JP7072384B2
(ja)
|
2014-09-15 |
2022-05-20 |
ジェネンテック， インコーポレイテッド |
抗体製剤
|
|
TWI599358B
(zh)
|
2014-09-16 |
2017-09-21 |
美國禮來大藥廠 |
組合療法
|
|
EP3197445B1
(en)
|
2014-09-22 |
2021-04-28 |
Zoser B. Salama |
Proline or proline derivatives for the treatment of dementia
|
|
JP2017531571A
(ja)
|
2014-10-01 |
2017-10-26 |
ダウ グローバル テクノロジーズ エルエルシー |
多層構造及びそれから作製される熱成形物品
|
|
US9921230B2
(en)
|
2014-10-08 |
2018-03-20 |
Rhode Island Hospital |
Methods for diagnosis and treatment of concussion or brain injury
|
|
WO2016059453A1
(en)
|
2014-10-16 |
2016-04-21 |
Fundacion Fraunhofer Chile Research |
Biomarkers and therapeutic targets for alzheimer's disease
|
|
WO2016073299A1
(en)
|
2014-11-04 |
2016-05-12 |
Dana-Farber Cancer Institute, Inc. |
Anti-galectin antibody biomarkers predictive of anti-immune checkpoint and anti-angiogenesis responses
|
|
CN107428820B
(zh)
|
2014-11-19 |
2022-03-22 |
阿克松神经系统科学公司 |
在阿尔茨海默氏病中的人源化tau抗体
|
|
MA41115A
(fr)
|
2014-12-02 |
2017-10-10 |
Biogen Int Neuroscience Gmbh |
Procédé de traitement de la maladie d'alzheimer
|
|
CA2874083C
(en)
|
2014-12-05 |
2024-01-02 |
Universite Laval |
Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
|
|
US9827308B2
(en)
|
2014-12-10 |
2017-11-28 |
Wisconsin Alumni Research Foundation |
Mini-intronic plasmid DNA vaccines in combination with LAG3 blockade
|
|
US10464999B2
(en)
|
2015-01-28 |
2019-11-05 |
Prothena Biosciences Limited |
Anti-transthyretin antibodies
|
|
US10654917B2
(en)
|
2015-01-29 |
2020-05-19 |
Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa |
Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders
|
|
CA2976005A1
(en)
|
2015-02-06 |
2016-08-11 |
Cell Idx, Inc. |
Antigen-coupled immunoreagents
|
|
TWI669314B
(zh)
|
2015-02-26 |
2019-08-21 |
美國禮來大藥廠 |
針對ｔａｕ之抗體及其用途
|
|
GB201504432D0
(en)
|
2015-03-17 |
2015-04-29 |
Electrophoretics Ltd |
Materials and methods for diagnosis and treatment of alzheimers disease
|
|
GB201505239D0
(en)
|
2015-03-27 |
2015-05-13 |
Neuro Bio Ltd |
Antibody
|
|
US12109346B2
(en)
|
2015-03-27 |
2024-10-08 |
Eliaz Therapeutics, Inc. |
Galectin-3 plasmapheresis therapy
|
|
US10828413B2
(en)
|
2015-03-27 |
2020-11-10 |
Eliaz Therapeutics, Inc. |
Patient selective apheresis
|
|
AU2016248208B2
(en)
|
2015-04-15 |
2022-03-24 |
Anaptysbio, Inc. |
Antibodies directed against interleukin 36 receptor (IL-36R)
|
|
SG10202110908WA
(en)
|
2015-05-04 |
2021-11-29 |
Cytomx Therapeutics Inc |
Anti-cd166 antibodies, activatable anti-cd166 antibodies, and methods of use thereof
|
|
EP3936524A3
(en)
|
2015-05-11 |
2022-06-15 |
F. Hoffmann-La Roche AG |
Compositions and methods of treating lupus nephritis
|
|
GB201508276D0
(en)
|
2015-05-14 |
2015-06-24 |
Electrophoretics Ltd |
A casein kinase 1 delta inhibitor
|
|
HUE048284T2
(hu)
|
2015-05-29 |
2020-07-28 |
Abbvie Inc |
Anti-CD40 antitestek és alkalmazásuk
|
|
CN114656573B
(zh)
|
2015-05-30 |
2024-09-27 |
分子模板公司 |
去免疫化的志贺毒素a亚基支架和包含它们的细胞靶向分子
|
|
BR112017026027A2
(pt)
|
2015-06-08 |
2018-08-14 |
Debiopharm Int Sa |
combinações de imunoconjugado anti-cd37 e anticorpo anti-cd20
|
|
US10203342B2
(en)
|
2015-06-11 |
2019-02-12 |
Nanosomix, Inc. |
Biomarkers and differential diagnosis of alzheimer's disease and other neurodegenerative disorders
|
|
PL3313877T3
(pl)
|
2015-06-24 |
2020-11-02 |
F. Hoffmann-La Roche Ag |
Humanizowane przeciwciała przeciwko białku tau(pS422) i sposoby stosowania
|
|
WO2016207240A1
(en)
|
2015-06-24 |
2016-12-29 |
F. Hoffmann-La Roche Ag |
Anti-transferrin receptor antibodies with tailored affinity
|
|
EP3316864A4
(en)
|
2015-06-30 |
2019-03-06 |
Nanotics, LLC |
COMPOSITIONS AND METHODS RELATED TO SCAVENGER PARTICLES
|
|
JO3711B1
(ar)
|
2015-07-13 |
2021-01-31 |
H Lundbeck As |
أجسام مضادة محددة لبروتين تاو وطرق استعمالها
|
|
EA039859B1
(ru)
|
2015-07-31 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
|
WO2017027691A1
(en)
|
2015-08-13 |
2017-02-16 |
New York University |
Antibody-based molecules selective for the {p}ser404 epitope of tau and their uses in the diagnosis and treatment of tauopathy
|
|
CN108135986B
(zh)
|
2015-08-13 |
2022-07-29 |
纽约大学 |
对于Tau的截短的Asp421表位特异性的基于抗体的分子和它们在诊断和治疗Tau疾病中的用途
|
|
ES2992591T3
(en)
|
2015-08-18 |
2024-12-16 |
Rakuten Medical Inc |
Compositions, combinations and related methods for photoimmunotherapy
|
|
IL319047A
(en)
|
2015-08-28 |
2025-04-01 |
Amunix Operating Inc |
Chimeric polypeptide composition and methods for its preparation and use
|
|
CA2997947A1
(en)
|
2015-09-09 |
2017-03-16 |
The Trustees Of Columbia University In The City Of New York |
Reduction of er-mam-localized app-c99 and methods of treating alzheimer's disease
|
|
EP3353214B1
(en)
|
2015-09-25 |
2021-08-18 |
Universität Duisburg-Essen |
Agents inhibiting kallikrein-8 for use in the prevention or treatment of alzheimer's disease
|
|
WO2017058944A1
(en)
|
2015-09-29 |
2017-04-06 |
Amgen Inc. |
Asgr inhibitors
|
|
AR106189A1
(es)
|
2015-10-02 |
2017-12-20 |
Hoffmann La Roche |
ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
|
|
CN114057884A
(zh)
|
2015-10-02 |
2022-02-18 |
豪夫迈·罗氏有限公司 |
双特异性抗人cd20/人转铁蛋白受体抗体及使用方法
|
|
EP4316512A3
(en)
|
2015-10-28 |
2024-04-24 |
The Trustees of The University of Pennsylvania |
Intrathecal administration of adeno-associated-viral vectors for gene therapy
|
|
JP6892859B2
(ja)
*
|
2015-11-09 |
2021-06-23 |
ガレクト・バイオテック・エイビイ |
新規ガラクトシドによるガレクチン阻害剤
|
|
MX2018005229A
(es)
|
2015-12-09 |
2019-04-29 |
F HoffmannLa Roche Ag |
Anticuerpo anti-cd20 de tipo ii y usos del mismo.
|
|
EP3397646A1
(en)
|
2015-12-28 |
2018-11-07 |
Massachusetts Institute of Technology |
Bispecific antibodies having constant region mutations and uses therefor
|
|
EP3397645A1
(en)
|
2015-12-28 |
2018-11-07 |
Innate Pharma |
VARIABLE REGIONS FOR NKp46 BINDING PROTEINS
|
|
JP6884155B2
(ja)
|
2016-02-18 |
2021-06-09 |
エンリヴェックス セラピューティクス リミテッド |
癌治療のための併用免疫療法及びサイトカイン制御療法
|
|
JP2019515874A
(ja)
|
2016-03-01 |
2019-06-13 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
改変された細胞死誘導を有するオビヌツズマブ変異体
|
|
CN116059390A
(zh)
|
2016-03-24 |
2023-05-05 |
拜耳制药股份公司 |
具有酶促可裂解基团的细胞毒性活性物质的前药
|
|
WO2017165681A1
(en)
|
2016-03-24 |
2017-09-28 |
Gensun Biopharma Inc. |
Trispecific inhibitors for cancer treatment
|
|
WO2017172757A1
(en)
|
2016-03-29 |
2017-10-05 |
Acadia Pharmaceuticals Inc. |
5-ht2a serotonin receptor inverse agonists or antagonists for use in reducing amyloid-beta peptides and accumulation of amyloid plaques
|
|
US11768203B2
(en)
|
2016-03-31 |
2023-09-26 |
University Of Southern California |
Highly sensitive and specific luciferase based reporter assay for antigen detection
|
|
EP3443001B1
(en)
|
2016-04-11 |
2025-04-30 |
Obsidian Therapeutics, Inc. |
REGULATED BIOCIRCUIT SYSTEMS
|
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
EP3448427A1
(en)
|
2016-04-29 |
2019-03-06 |
CureVac AG |
Rna encoding an antibody
|
|
EP3464639A4
(en)
|
2016-05-31 |
2020-01-01 |
Goetzl, Edward, J. |
DIAGNOSTIC METHOD AND DRUG EFFECT TEST METHOD FOR DEMENTIA WITH THE USE OF ASTROCYTE-DERIVED EXOSOMES
|
|
WO2017218911A1
(en)
|
2016-06-17 |
2017-12-21 |
Abbott Laboratories |
BIOMARKERS TO PREDICT NEW ONSET HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF)
|
|
EP4295853A3
(en)
|
2016-06-28 |
2024-03-06 |
Emergent BioDefense Operations Lansing LLC |
Formulations of brincidofovir
|
|
HUE053679T2
(hu)
|
2016-07-12 |
2021-07-28 |
H Lundbeck As |
Hiperfoszforilezett TAU-ra specifikus antitestek és eljárások ezek alkalmazására
|
|
US12123874B2
(en)
|
2016-07-18 |
2024-10-22 |
Cell Idx, Inc. |
Reagent compounds, compositions, kits, and methods for amplified assays
|
|
EP3487524A4
(en)
|
2016-07-20 |
2020-03-25 |
Anahit Ghochikyan |
HUMANIZED ANTI-TAU ANTIBODIES, COMPOSITIONS AND MANUFACTURING METHODS AND METHODS OF USE IN THE TREATMENT, DIAGNOSIS AND MONITORING OF TAUOPATHIES
|
|
WO2018019188A1
(zh)
|
2016-07-23 |
2018-02-01 |
博瑞生物医药（苏州）股份有限公司 |
核苷氨基磷酸酯类前药的多晶型及其制备方法
|
|
JP6942358B2
(ja)
|
2016-08-09 |
2021-09-29 |
国立大学法人 東京医科歯科大学 |
Ｈｍｇｂ１に対する抗体、及びそれを含有するアルツハイマー病を治療又は予防するための組成物
|
|
US10076552B2
(en)
|
2016-08-09 |
2018-09-18 |
DATT MEDIPRODUCTS LIMITED and DATT LIFE SCIENCE PVT. LTD. |
Multifunctional formulation comprised of natural ingredients and method of preparation/manufacturing thereof
|
|
EP4559479A3
(en)
|
2016-08-30 |
2025-06-11 |
Dana-Farber Cancer Institute, Inc. |
Drug delivery compositions and uses thereof
|
|
WO2018058098A1
(en)
|
2016-09-26 |
2018-03-29 |
Yale University |
Compounds and methods for treating or preventing alzheimer's disease
|
|
US10662226B2
(en)
|
2016-10-28 |
2020-05-26 |
The Regents of the University of Caiifomia |
Synthetic beta-amyloid peptides capable of forming stable antigenic oligomers
|
|
TW201827467A
(zh)
|
2016-11-03 |
2018-08-01 |
比利時商健生藥品公司 |
焦穀胺酸類澱粉蛋白－β之抗體及其用途
|
|
EP3324186B1
(en)
|
2016-11-21 |
2020-09-16 |
Ruhr-Universität Bochum |
Method for the preselection of drugs for protein misfolding diseases
|
|
MX2019006374A
(es)
|
2016-12-02 |
2019-09-11 |
Univ Southern California |
Receptores inmunes sinteticos y metodos de usos de ellos.
|
|
KR102557126B1
(ko)
|
2016-12-07 |
2023-07-18 |
몰레큘러 템플레이츠, 인코퍼레이션. |
부위 특이적 접합을 위한 시가 독소 a 서브유닛 작동체 폴리펩타이드, 시가 독소 작동체 스캐폴드, 및 세포-표적화 분자
|
|
AU2017384528A1
(en)
|
2016-12-19 |
2019-07-04 |
Ichnos Sciences SA |
Novel TNFR agonists and uses thereof
|
|
JP7247091B2
(ja)
|
2016-12-20 |
2023-03-28 |
エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト |
抗ｃｄ２０／抗ｃｄ３二重特異性抗体と４－１ｂｂ（ｃｄ１３７）アゴニストの併用療法
|
|
PE20191235A1
(es)
|
2016-12-21 |
2019-09-11 |
Bayer Pharma AG |
Conjugados de ligando-farmaco (adcs) con grupos escindibles enzimaticamente
|
|
US10364286B2
(en)
|
2016-12-22 |
2019-07-30 |
H. Lundbeck A/S |
Monoclonal anti-alpha-synuclein antibodies for preventing tau aggregation
|
|
JP7264482B2
(ja)
|
2016-12-23 |
2023-04-25 |
ブルーフィン バイオメディシン， インコーポレイテッド |
抗ｓｅｚ６ｌ２抗体および抗体薬物コンジュゲート
|
|
WO2018140427A1
(en)
|
2017-01-25 |
2018-08-02 |
Molecular Templates, Inc. |
Cell-targeting molecules comprising de-immunized, shiga toxin a subunit effectors and cd8+ t-cell epitopes
|
|
AU2018212860A1
(en)
|
2017-01-30 |
2019-08-15 |
National Research Council Of Canada |
Blood-brain barrier transmigrating compounds and uses thereof
|
|
CN108395482B
(zh)
|
2017-02-08 |
2021-02-05 |
西比曼生物科技（香港）有限公司 |
一种靶向cd20抗原嵌合抗原受体的构建及其工程化t细胞的活性鉴定
|
|
US10473672B2
(en)
|
2017-02-09 |
2019-11-12 |
Kaohsiung Chang Gung Memorial Hospital |
Methods for diagnosing and treating Alzheimers disease using G72 protein and SLC7A11 mRNA as biomarkers
|
|
WO2018156250A1
(en)
|
2017-02-21 |
2018-08-30 |
Remd Biotherapeutics, Inc. |
Cancer treatment using antibodies that bind cytotoxic t-lymphocyte antigen-4 (ctla-4)
|
|
US20190374650A1
(en)
|
2017-02-22 |
2019-12-12 |
The Regents Of The University Of Michigan |
Compositions and methods for delivery of polymer/biomacromolecule conjugates
|
|
CA3056837A1
(en)
|
2017-03-27 |
2018-10-04 |
F. Hoffmann-La Roche Ag |
Improved antigen binding receptors
|
|
US20230399414A1
(en)
|
2017-03-31 |
2023-12-14 |
Genmab Holding B.V, |
Bispecific anti-cd37 antibodies, monoclonal anti-cd37 antibodies and methods of use thereof
|
|
IL269645B2
(en)
|
2017-03-31 |
2025-05-01 |
Genmab Holding B V |
Bispecific anti-cd37 antibodies, monoclonal anti-cd37 antibodies and methods of use thereof
|
|
TW202515920A
(zh)
|
2017-04-11 |
2025-04-16 |
美商因荷布瑞克斯生物科學公司 |
具有經受限cd3結合的多重特異性多肽構築體及使用其之方法
|
|
CN108728465A
(zh)
|
2017-04-14 |
2018-11-02 |
深圳新诺微环生物科技有限公司 |
一种表达靶细胞-效应细胞桥接器的微环dna载体及其制备方法和应用
|
|
JP7382232B2
(ja)
|
2017-05-02 |
2023-11-16 |
メルク・シャープ・アンド・ドーム・エルエルシー |
抗ｌａｇ３抗体の製剤および抗ｌａｇ３抗体と抗ｐｄ－１抗体との共製剤
|
|
CN108864290B
(zh)
|
2017-05-08 |
2021-12-07 |
上海津曼特生物科技有限公司 |
双特异性重组蛋白及其应用
|
|
CN111032670A
(zh)
|
2017-05-12 |
2020-04-17 |
卡莱克汀科学有限责任公司 |
用于治疗系统性胰岛素抗性病症的化合物及其用途
|
|
EP3625252A1
(en)
|
2017-05-18 |
2020-03-25 |
H. Hoffnabb-La Roche Ag |
Reduction of application-related side reaction of a therapeutic antibody
|
|
JP7235733B2
(ja)
|
2017-06-05 |
2023-03-08 |
ヤンセン バイオテツク，インコーポレーテツド |
Ｐｄ－１に特異的に結合する抗体、及び使用方法
|
|
US11214835B1
(en)
|
2017-06-06 |
2022-01-04 |
University Of South Florida |
Methods and compositions for diagnosis and management of neurodegerative diseases
|
|
MX2019014960A
(es)
|
2017-06-12 |
2020-08-06 |
Obsidian Therapeutics Inc |
Composiciones de fosfodiesterasa de tipo 5 (pde5) y métodos de inmunoterapia.
|
|
WO2019010224A1
(en)
|
2017-07-03 |
2019-01-10 |
Torque Therapeutics, Inc. |
FUSION MOLECULES TARGETING IMMUNE REGULATORY CELLS AND USES THEREOF
|
|
US10662246B2
(en)
|
2017-07-10 |
2020-05-26 |
New York University |
Monoclonal antibody to treat alzheimer's disease, prion disease, frontotemporal dementias and traumatic brain injury/chronic traumatic encephalopathy
|
|
KR20200027971A
(ko)
|
2017-07-14 |
2020-03-13 |
싸이톰스 테라퓨틱스, 인크. |
항-cd166 항체 및 이의 용도
|
|
CN111201030B
(zh)
|
2017-07-25 |
2024-11-01 |
真和制药有限公司 |
通过阻断tim-3和其配体的相互作用治疗癌症
|
|
US20190029970A1
(en)
|
2017-07-31 |
2019-01-31 |
The Chinese University Of Hong Kong |
Fatty acid conjugated nanoparticles and uses thereof
|
|
CA3069745A1
(en)
|
2017-08-03 |
2019-02-07 |
Galectin Sciences, Llc |
Compounds for the prevention and treatment of medical disorders and uses thereof
|
|
MX2020001493A
(es)
|
2017-08-08 |
2020-03-24 |
Hoffmann La Roche |
Tratamiento con obinutuzumab nuevo subgrupo de pacientes con nuevo linfoma de celulas b grandes difusas (dlbcl).
|
|
CN107881160A
(zh)
|
2017-08-11 |
2018-04-06 |
百奥泰生物科技(广州)有限公司 |
一种由基因组被编辑的cho宿主细胞产生的具有独特糖谱的重组抗体及其制备方法
|
|
BR112020005938A2
(pt)
|
2017-09-27 |
2020-11-17 |
University Of Southern California |
célula imune ou população de células imunes da mesma, célula efetora imune ou célula-tronco, célula que apresenta antígeno, polinucleotídeo recombinante, vetor, composição que compreende uma célula imune efetora ou uma célula-tronco, métodos para produzir uma célula efetora imune que expressa receptor imune de ocorrência não natural, para gerar uma população de células manipuladas por rna, para fornecer imunidade antidoença em um indivíduo, para tratar ou prevenir uma doença associada à expressão de um antígeno, e, uso
|
|
EP3466975A1
(en)
|
2017-10-05 |
2019-04-10 |
Laboratoire Français du Fractionnement et des Biotechnologies |
A specific binding molecule directed against galectin-3 protein
|
|
US20200330592A1
(en)
|
2017-10-09 |
2020-10-22 |
Keith Black |
Compositions and methods of treating alzheimer's and other amyloid related diseases
|
|
EP4509527A3
(en)
|
2017-10-18 |
2025-04-30 |
REGENXBIO Inc. |
Post-translationally modified fully human antibody therapeutic agents
|
|
CN118772271A
(zh)
|
2017-10-25 |
2024-10-15 |
爱兰细胞技术公司 |
H1.0k180me2抗体、其制造方法和用途
|
|
CN111527097A
(zh)
|
2017-10-31 |
2020-08-11 |
卡莱克汀科学有限责任公司 |
用于治疗全身性胰岛素抵抗障碍的硒代半乳糖苷化合物及其用途
|
|
WO2019094679A1
(en)
|
2017-11-10 |
2019-05-16 |
The Regents Of The University Of California |
BRAIN DELIVERY OF THE BACE INHIBITOR SAPPALPHA, ANTIBODIES, OR INHIBITORY RNA's USING SYNTHETIC EXOSOMES (DEFORMABLE NANOVESICLES, DNVs)
|
|
PH12020550694A1
(en)
|
2017-11-29 |
2021-04-12 |
Prothena Biosciences Ltd |
Lyophilized formulation of a monoclonal antibody against transthyretin
|
|
SG11202005007VA
(en)
|
2017-12-06 |
2020-06-29 |
Basf As |
Fatty acid derivatives for treating non-alcoholic steatohepatitis
|
|
JP2021508246A
(ja)
|
2017-12-21 |
2021-03-04 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
新規抗原結合部分の特異性試験のためのｃａｒ−ｔ細胞アッセイ
|
|
CN109985231A
(zh)
|
2018-01-02 |
2019-07-09 |
上海清流生物医药科技有限公司 |
一种蛋白在制备预防和治疗痴呆症的药物中的应用
|
|
EP3737472A1
(en)
|
2018-01-09 |
2020-11-18 |
Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie |
Modulators of c1q, in particular of the interaction of apoe with c1q, and uses of the modulators in the therapy of neuronal diseases and inflammation
|
|
KR101868343B1
(ko)
|
2018-01-16 |
2018-06-18 |
재단법인대구경북과학기술원 |
콧물 시료의 베타 아밀로이드 올리고머를 이용한 알츠하이머 질환의 진행 단계 스크리닝용 조성물 및 이를 이용한 알츠하이머 질환의 진행 단계 스크리닝 방법
|
|
US12180285B2
(en)
|
2018-02-01 |
2024-12-31 |
Memorial Sloan Kettering Cancer Center |
Antibodies to galectin-3 and methods of use thereof
|
|
WO2019161384A1
(en)
|
2018-02-19 |
2019-08-22 |
New York University |
Tau single domain antibodies
|
|
CN112040959A
(zh)
|
2018-02-23 |
2020-12-04 |
真和制药有限公司 |
通过阻断vista和其结合伴侣的相互作用治疗癌症
|
|
EP3755148A4
(en)
|
2018-02-23 |
2021-12-15 |
RHNanoPharma |
SALSALATE NANOSUSPENSIONS AND THEIR PROCESSES FOR USE
|
|
WO2019165421A1
(en)
|
2018-02-26 |
2019-08-29 |
Minerva Biotechnologies Corporation |
Diagnostic methods using anti-muc1* antibodies
|
|
NL2020520B1
(en)
|
2018-03-02 |
2019-09-12 |
Labo Bio Medical Invest B V |
Multispecific binding molecules for the prevention, treatment and diagnosis of neurodegenerative disorders
|
|
MX2020009991A
(es)
|
2018-03-28 |
2020-10-14 |
Axon Neuroscience Se |
Metodos basados en anticuerpos para detectar y tratar la enfermedad de alzheimer.
|
|
US20210008204A1
(en)
|
2018-03-29 |
2021-01-14 |
Microvascular Therapeutics LLC |
Compositions and methods of detecting and treating alzheimer's disease
|
|
CN112584901A
(zh)
|
2018-04-04 |
2021-03-30 |
真和制药有限公司 |
用于阻断非糖基化的pd-1多肽之间的相互作用的方法和组合物
|
|
TW202010757A
(zh)
|
2018-04-11 |
2020-03-16 |
美商英伊布里克斯公司 |
具有經受限cd3結合的多重特異性多肽構築體以及相關方法及用途
|
|
JP7318948B2
(ja)
|
2018-04-13 |
2023-08-01 |
国立大学法人京都大学 |
微生物由来化合物を用いたアルツハイマー病の予防、治療、または診断薬
|
|
PE20210442A1
(es)
|
2018-04-16 |
2021-03-08 |
Hoffmann La Roche |
Anticuerpos para radionuclidos quelados
|
|
WO2019207159A1
(en)
|
2018-04-27 |
2019-10-31 |
Fondazione Ebri Rita Levi-Montalcini |
Antibody directed against a tau-derived neurotoxic peptide and uses thereof
|
|
US11085935B2
(en)
|
2018-05-03 |
2021-08-10 |
Washington University |
Methods of treating based on site-specific tau phosphorylation
|
|
US20210207167A1
(en)
|
2018-05-16 |
2021-07-08 |
Voyager Therapeutics, Inc. |
Aav serotypes for brain specific payload delivery
|
|
WO2019231957A1
(en)
|
2018-05-30 |
2019-12-05 |
National Health Research Institutes |
Anti-abeta antibodies and uses thereof
|
|
WO2019241315A1
(en)
|
2018-06-12 |
2019-12-19 |
Obsidian Therapeutics, Inc. |
Pde5 derived regulatory constructs and methods of use in immunotherapy
|
|
AU2019291061B2
(en)
|
2018-06-19 |
2025-04-10 |
Universidad Pablo De Olavide |
Compositions for treating and/or preventing protein-aggregation diseases
|
|
WO2019246422A1
(en)
|
2018-06-20 |
2019-12-26 |
Sanford Burnham Prebys Medical Discovery Institute |
Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of alzheimer's disease
|
|
KR20210042326A
(ko)
|
2018-07-11 |
2021-04-19 |
모멘타 파머슈티컬스 인코포레이티드 |
조작된 Fc-항원 결합 도메인 작제물에 관련된 조성물 및 방법
|
|
MX2021000778A
(es)
|
2018-07-24 |
2021-03-31 |
Eisai R&D Man Co Ltd |
Metodos de tratamiento y prevencion de la enfermedad de alzheimer.
|
|
EP3836966A4
(en)
|
2018-08-17 |
2022-06-08 |
Ab Studio Inc. |
CATALYTIC ANTIBODIES AND METHODS OF USE THEREOF
|
|
JP7525160B2
(ja)
|
2018-08-31 |
2024-07-30 |
Ｂｌｏｏｍ Ｔｅｃｈｎｏｌｏｇｙ 株式会社 |
終末糖化産物に対する抗体およびその使用
|
|
KR20210057113A
(ko)
|
2018-09-11 |
2021-05-20 |
워싱턴 유니버시티 |
항-trem-2 작용제 항체
|
|
TWI825177B
(zh)
|
2018-09-18 |
2023-12-11 |
大陸商北京強新生物科技有限公司 |
非酒精性脂肪性肝病的治療
|
|
EP3854875A4
(en)
|
2018-09-21 |
2022-07-06 |
National University Corporation Tokyo Medical and Dental University |
HUMAN MONOCLONAL ANTIBODY SPECIFIC BINDING TO HUMAN HMGB1 AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF ALZHEIMER'S DISEASE CONTAINING THE HUMAN MONOCLONAL ANTIBODY
|
|
EP3861023A1
(en)
|
2018-10-04 |
2021-08-11 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin |
Humanised anti-n-truncated amyloid beta monoclonal antibody
|
|
EP3861352A4
(en)
|
2018-10-04 |
2022-08-03 |
University of Manitoba |
NOVEL BIOMARKER FOR HUMAN ALZHEIMER'S DISEASE
|
|
JP7453219B2
(ja)
|
2018-10-11 |
2024-03-19 |
インヒブリックス， インコーポレイテッド |
Ｐｄ－１単一ドメイン抗体およびその治療用組成物
|
|
JP2022505101A
(ja)
|
2018-10-18 |
2022-01-14 |
ファンダメンタル ファーマ ゲーエムベーハー |
Ｎｍｄａ受容体媒介毒性を調節するための新規の方法
|
|
EP3643319A1
(en)
|
2018-10-25 |
2020-04-29 |
Grifols Worldwide Operations Limited |
Use of low volume plasma exchange for the treatment of alzheimer's disease in early and middle stages
|
|
BR112021008105A2
(pt)
|
2018-10-29 |
2021-08-03 |
Biogen Ma Inc. |
variantes de fc5 humanizadas e estabilizadas para intensificação de transporte através de barreira hematoencefálica
|
|
ES2992137T3
(es)
|
2018-10-29 |
2024-12-09 |
Cyclo Therapeutics Inc |
Métodos para tratar la enfermedad de Alzheimer con HP-[ß]-ciclodextrina
|
|
CN111153995B
(zh)
|
2018-11-07 |
2020-12-25 |
上海怀越生物科技有限公司 |
Nkg2a抗体及其制备方法和应用
|
|
CA3120970A1
(en)
|
2018-11-26 |
2020-06-04 |
Denali Therapeutics Inc. |
Methods for treating dysregulated lipid metabolism
|
|
EP3902834A4
(en)
|
2018-11-30 |
2022-08-24 |
Memorial Sloan Kettering Cancer Center |
HETERODIMERS TETRAVALENTS AND SPECIFIC ANTIBODY COMPOSITIONS AND USES THEREOF
|
|
EP3890618A4
(en)
|
2018-12-04 |
2023-01-11 |
The Brain Protection Company PTY Ltd |
COMBINATIONAL THERAPIES COMPRISING IMPLANTABLE DAMPING DEVICES AND THERAPEUTIC AGENTS FOR TREATING A CONDITION AND SYSTEMS AND METHODS OF USE THEREOF
|
|
US12365724B2
(en)
|
2018-12-10 |
2025-07-22 |
New York University |
Antibodies binding to phospho-tau comprising phosphorylated Ser396 and Ser404 and methods of detecting thereof
|
|
MY198034A
(en)
|
2018-12-21 |
2023-07-27 |
Hoffmann La Roche |
Tumor-targeted agonistic cd28 antigen binding molecules
|
|
JP2022037257A
(ja)
|
2018-12-27 |
2022-03-09 |
クリニジェン株式会社 |
アルツハイマー病を治療又は予防する為の抗ウイルス剤及びその使用
|
|
EP3911371A4
(en)
|
2019-01-18 |
2023-04-26 |
University of Southern California |
METHODS AND COMPOSITIONS FOR IMPROVING THE SAFETY AND EFFICACY OF CELL THERAPY
|
|
WO2020154475A1
(en)
|
2019-01-23 |
2020-07-30 |
Molecular Templates, Inc. |
Proteins comprising modified immunoglobulin variable light chains
|
|
CA3127113A1
(en)
|
2019-01-30 |
2020-08-06 |
Dongxu Sun |
Anti-gal3 antibodies and uses thereof
|
|
CN111518205B
(zh)
|
2019-02-01 |
2022-03-29 |
长春金赛药业有限责任公司 |
人源化抗Aβ单克隆抗体及其应用
|
|
BR112021014794A2
(pt)
|
2019-02-08 |
2021-10-05 |
Ac Immune S.A. |
Método de administração segura de vacina de peptídeo de tau fosforilada
|
|
SG11202106717PA
(en)
|
2019-02-08 |
2021-07-29 |
Prothena Biosciences Ltd |
Antibodies recognizing tau
|
|
PL240124B1
(pl)
|
2019-02-21 |
2022-02-21 |
Univ Jagiellonski |
Sposób określania stopnia uszkodzenia nerek pojawiającego się u chorych z cukrzycą
|
|
CN120329441A
(zh)
|
2019-02-22 |
2025-07-18 |
纪念斯隆凯特琳癌症中心 |
Cd33抗体和使用所述抗体治疗癌症的方法
|
|
JP2022523200A
(ja)
|
2019-02-26 |
2022-04-21 |
シートムエックス セラピューティクス，インコーポレイテッド |
活性化可能な免疫チェックポイント阻害剤とコンジュゲートされた活性化可能な抗体の組み合わせ療法
|
|
EP3927710A4
(en)
|
2019-03-08 |
2022-12-21 |
University of Virginia Patent Foundation |
COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF ALZHEIMER'S DISEASE
|
|
TW202102270A
(zh)
|
2019-03-21 |
2021-01-16 |
美商伊繆諾金公司 |
製備細胞結合劑-藥物結合物之方法
|
|
CN113891746B
(zh)
|
2019-03-26 |
2025-05-06 |
詹森药业有限公司 |
焦谷氨酸淀粉样蛋白-β的抗体及其用途
|
|
TW202102506A
(zh)
|
2019-03-29 |
2021-01-16 |
美商伊繆諾金公司 |
苯二氮平衍生物
|
|
US20220195071A1
(en)
|
2019-03-29 |
2022-06-23 |
Torque Therapeutics,Inc. |
Immunotherapeutic compositions and use thereof
|
|
WO2020210067A1
(en)
|
2019-04-08 |
2020-10-15 |
Phanes Therapeutics, Inc. |
Humanized anti-dll3 chimeric antigen receptors and uses thereof
|
|
PH12021552683A1
(en)
|
2019-04-24 |
2022-03-21 |
Ac Immune Sa |
Heterologous administration of tau vaccines
|
|
CA3137284A1
(en)
|
2019-04-24 |
2020-10-29 |
Regenxbio Inc. |
Fully-human post-translationally modified antibody therapeutics
|
|
EP4316524A3
(en)
|
2019-04-26 |
2024-04-24 |
ImmunoGen, Inc. |
Camptothecin derivatives
|
|
EP3965807A4
(en)
|
2019-05-06 |
2023-08-30 |
The Regents of the University of California |
NON-HLA MARKERS OF TRANSPLANT REJECTION
|
|
EP3965798A4
(en)
|
2019-05-09 |
2023-06-14 |
University of the Witwatersrand, Johannesburg |
METHOD OF REDUCING THE CONCENTRATION OF TAU (T) PROTEIN AND/OR PHOSPHORYLATED TAU (T) PROTEIN
|
|
CN114206340A
(zh)
|
2019-05-14 |
2022-03-18 |
豪夫迈·罗氏有限公司 |
使用抗cd79b免疫缀合物治疗滤泡性淋巴瘤的方法
|
|
US20220226514A1
(en)
|
2019-05-17 |
2022-07-21 |
Cytomx Therapeutics, Inc. |
Methods and compositions for determining the biodistribution of activatable anti-cd166 antibody conjugates
|
|
WO2020247371A1
(en)
|
2019-06-04 |
2020-12-10 |
Verseau Therapeutics, Inc. |
Anti-psgl-1 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof
|
|
CN116987197A
(zh)
|
2019-06-20 |
2023-11-03 |
成都恩沐生物科技有限公司 |
共价多特异性抗体
|
|
EP3986439A4
(en)
|
2019-06-21 |
2023-10-04 |
University of Kansas |
COMPOSITIONS AND METHODS USEFUL IN THE TREATMENT OF BRAIN DISEASES
|
|
KR20220038068A
(ko)
|
2019-06-26 |
2022-03-25 |
아뮤닉스 파마슈티컬스, 인크. |
Cd3 항원 결합 단편 및 이를 포함하는 조성물
|
|
EP3990022A4
(en)
|
2019-06-26 |
2023-06-28 |
Memorial Sloan Kettering Cancer Center |
Anti-cd33 antibodies for treating cancer
|
|
CA3146118A1
(en)
|
2019-06-28 |
2020-12-30 |
The Regents Of The University Of California |
Methods and compositions for treating alzheimer's disease
|
|
BR112021025161A2
(pt)
|
2019-07-01 |
2022-01-25 |
Eisai R&D Man Co Ltd |
Anticorpo anti-epha4
|
|
EP3994159A4
(en)
|
2019-07-05 |
2023-08-09 |
University of Florida Research Foundation, Incorporated |
METHODS OF TREATING NEUROLOGICAL DISEASES ASSOCIATED WITH THE RAN PROTEIN
|
|
JP7194085B2
(ja)
|
2019-07-09 |
2022-12-21 |
日立Astemo株式会社 |
操舵制御装置、操舵制御方法、及び操舵制御システム
|
|
CN113242745A
(zh)
|
2019-07-15 |
2021-08-10 |
科利耳有限公司 |
经皮功率和数据通信链路
|
|
WO2021011673A2
(en)
|
2019-07-16 |
2021-01-21 |
Ming Jin |
Neutralizing anti-amyloid beta antibodies for the treatment of alzheimer's disease
|
|
JP7242858B2
(ja)
|
2019-07-17 |
2023-03-20 |
株式会社東芝 |
太陽電池モジュールおよびタンデム型太陽電池
|
|
DE102019119426A1
(de)
|
2019-07-17 |
2021-01-21 |
Endress+Hauser SE+Co. KG |
Feldgerät der Automatisierungstechnik
|
|
US20220275037A1
(en)
|
2019-07-19 |
2022-09-01 |
Dingding MO |
ß-AMYLOID CYCLIC RIBONUCLEIC ACID, POLYPEPTIDE, AND APPLICATION THEREOF
|
|
AU2020325315A1
(en)
|
2019-08-07 |
2022-03-24 |
Aqualung Therapeutics Corp. |
Anti-NAMPT antibodies and uses thereof
|
|
JP2022544277A
(ja)
|
2019-08-14 |
2022-10-17 |
ベーリンガー インゲルハイム エルツェーファウ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト |
カスパーゼ－２バリアント
|
|
JP2022545834A
(ja)
|
2019-08-30 |
2022-10-31 |
クイル ピュージェット サウンド バイオセラピューティクス コーポレーション |
抗ｃｄ２０抗体、抗ｃｄ３７抗体、およびこれらの混合物
|
|
WO2021048619A2
(en)
|
2019-09-09 |
2021-03-18 |
Axon Neuroscience Se |
Biomarkers and treatments of alzheimer's disease and mild cognitive impairment
|
|
WO2021047559A1
(zh)
|
2019-09-09 |
2021-03-18 |
武汉友芝友生物制药有限公司 |
一种断裂型内含肽、使用其的重组多肽的制备方法
|
|
CA3153700A1
(en)
|
2019-09-09 |
2021-03-18 |
Scribe Therapeutics Inc. |
Compositions and methods for use in immunotherapy
|
|
CA3146616A1
(en)
|
2019-09-12 |
2021-03-18 |
Matthew Dominic CASCINO |
Compositions and methods of treating lupus nephritis
|
|
US11202068B2
(en)
|
2019-09-16 |
2021-12-14 |
Mediatek Inc. |
Method and apparatus of constrained cross-component adaptive loop filtering for video coding
|
|
CA3151223A1
(en)
|
2019-09-17 |
2021-03-25 |
Pravin T.P. Kaumaya |
Human anti-pd-l1 peptide vaccines and methods of their use
|
|
CA3151237A1
(en)
|
2019-09-19 |
2021-03-25 |
Ramesh Baliga |
Multimeric antibodies with enhanced selectivity for cells with high target density
|
|
AR122307A1
(es)
|
2019-10-04 |
2022-08-31 |
Chugai Pharmaceutical Co Ltd |
Agente de supresión de la proliferación celular de cáncer cd20 positivo tolerante a obinutuzumab, y composición farmacéutica, medicamento, fabricación, procedimiento de supresión de la proliferación celular, procedimiento de tratamiento, anticuerpo anti-cd20 de tipo ii, compuesto, sus combinaciones, y agente potenciador y agente inductor, relacionados con estos
|
|
WO2021071830A1
(en)
|
2019-10-07 |
2021-04-15 |
University Of Virginia Patent Foundation |
Modulating lymphatic vessels in neurological disease
|
|
CN112641953A
(zh)
|
2019-10-10 |
2021-04-13 |
复旦大学 |
一种靶向功能分子修饰的抗体复合物
|
|
IL292363A
(en)
|
2019-10-22 |
2022-06-01 |
Biogen Ma Inc |
Anti-beta-amyloid antibody for treating alzheimer's disease
|
|
ES2821599A1
(es)
|
2019-10-24 |
2021-04-26 |
Univ Del Pais Vasco / Euskal Herriko Unibertsitatea |
Compuestos y metodos para el tratamiento de la enfermedad de alzheimer
|
|
US20220402998A1
(en)
|
2019-10-30 |
2022-12-22 |
The Texas A&M University System |
Protease switch for dual targets chimeric antigen receptor t cell therapy
|
|
GB201915855D0
(en)
|
2019-10-31 |
2019-12-18 |
Univ Oxford Innovation Ltd |
An extracellular vesicle
|
|
KR20220131221A
(ko)
|
2019-11-13 |
2022-09-27 |
아뮤닉스 파마슈티컬스, 인크. |
바코드화된 xten 폴리펩티드 및 이의 조성물, 및 이의 제조 방법 및 사용 방법
|
|
JP2023506381A
(ja)
|
2019-11-28 |
2023-02-16 |
マックマスター、ユニバーシティー |
細胞外小胞をプログラムするための組換えポリペプチド
|
|
US20230094463A1
(en)
|
2019-12-06 |
2023-03-30 |
Truebinding, Inc. |
Antibodies that disrupt the interaction of gal3 and insulin receptor or integrins and methods of use thereof
|
|
US20230046007A1
(en)
|
2019-12-17 |
2023-02-16 |
Cirlo Gmbh |
Tubular shaped elongated catheter device assemblies for interacting with components of bodily fluids, method for recovering cells, cell aggregates and exosomes from a tubular shaped elongated catheter device and smart tubular shaped elongated catheter device assemblies for monitoring interaction with components of bodily fluids
|
|
US11913945B2
(en)
|
2020-01-02 |
2024-02-27 |
Hoffmann-La Roche Inc. |
Method for determining the amount of a therapeutic antibody in the brain
|
|
JP2023510866A
(ja)
|
2020-01-13 |
2023-03-15 |
トゥルーバインディング，インコーポレイテッド |
抗ｇａｌ３抗体および使用方法
|
|
JP7692918B6
(ja)
|
2020-01-21 |
2025-07-17 |
上海復宏漢霖生物技術股▲フン▼有限公司 |
抗ｌａｇ３モノクローナル抗体、その製造方法および使用
|
|
MX2022009306A
(es)
|
2020-01-29 |
2022-09-26 |
Inhibrx Inc |
Loseta de nucleo de espuma densificada (dfc) con linea de anticuerpos de dominio individual de cd28 y constructos multivalentes y multiespecíficas de los mismos.
|
|
US20230349924A1
(en)
|
2020-02-05 |
2023-11-02 |
Sumitomo Pharma Co., Ltd. |
Determination agent and determination method for tauopathy and dementia-related diseases
|
|
US20230116380A1
(en)
|
2020-02-12 |
2023-04-13 |
The Scripps Research Institute |
Long-acting gm-csf and methods of use
|
|
WO2021163681A2
(en)
|
2020-02-14 |
2021-08-19 |
The Trustees Of Columbia University In The City Of New York |
Combination of retromer pharmacological chaperones and exogenous retromer for the treatment of alzheimer's disease and other neurodegenerative diseases and disorders
|
|
WO2021167723A1
(en)
|
2020-02-17 |
2021-08-26 |
Board Of Regents, The University Of Texas System |
Chimeric scavenger receptors targeted to phosphorylated tau (ptau) and uses thereof
|
|
AU2021232512A1
(en)
|
2020-03-02 |
2022-09-29 |
The Regents Of The University Of California |
Chimeric antigen receptors and related methods and compositions for the treatment of cancer
|
|
GB202003428D0
(en)
|
2020-03-10 |
2020-04-22 |
Univ Dundee |
IL-10 mutiens
|
|
CN113384710A
(zh)
|
2020-03-14 |
2021-09-14 |
杭州星鳌生物科技有限公司 |
新型免疫激动剂复合物的组成及其在抗多种疾病药物中的应用
|
|
BR112022018359A2
(pt)
|
2020-03-16 |
2023-01-24 |
Univ Southern California |
Novos domínios de ligação ao antígeno e receptores de antígeno sintéticos incorporando os mesmos
|
|
US20230104705A1
(en)
|
2020-03-17 |
2023-04-06 |
Cellular Biomedicine Group Inc. |
Combined chimeric antigen receptor targeting cd19 and cd20 and application thereof
|
|
CN113402612A
(zh)
|
2020-03-17 |
2021-09-17 |
西比曼生物科技（香港）有限公司 |
靶向cd19和cd20的联合嵌合抗原受体及其应用
|
|
US20230212255A1
(en)
|
2020-03-17 |
2023-07-06 |
Cellular Biomedicine Group Inc. |
Combined chimeric antigen receptor targeting cd19 and cd20 and applications thereof
|
|
JP2023517757A
(ja)
|
2020-03-20 |
2023-04-26 |
ウニベルジテート ハイデルベルク |
所望の作用部位への薬剤の導入のためのコロイド担体系
|
|
US20230107479A1
(en)
|
2020-03-23 |
2023-04-06 |
G3 Pharmaceuticals, Inc. |
Methods and compositions for preventing and treating fibrosis resulting from a coronavirus infection
|
|
CA3176937A1
(en)
|
2020-03-24 |
2021-09-30 |
Talengen International Limited |
Method and drug for promoting degradation of misfolded protein and aggregate thereof
|
|
JP7576861B2
(ja)
|
2020-03-24 |
2024-11-01 |
タレンゲン インターナショナル リミテッド |
アルツハイマー病を治療する方法及び薬剤
|
|
US20230141177A1
(en)
|
2020-03-31 |
2023-05-11 |
The University Of British Columbia |
Antibodies to misfolded amyloid beta
|
|
JP2023521155A
(ja)
|
2020-04-07 |
2023-05-23 |
ジー３ピー・インコーポレイテッド |
網膜神経障害を予防及び治療するための方法及び組成物
|
|
JP7792346B2
(ja)
|
2020-04-07 |
2025-12-25 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
中枢神経系及び非中枢神経系への治療薬の送達のための合成エキソソームの製造
|
|
US20230151104A1
(en)
|
2020-04-23 |
2023-05-18 |
Remd Biotherapeutics, Inc. |
Chemokine receptor 4 (cxcr4) antagonist antibodies
|
|
EP4139359A1
(en)
|
2020-04-24 |
2023-03-01 |
Genentech, Inc. |
Methods of using anti-cd79b immunoconjugates
|
|
IL296664A
(en)
|
2020-04-24 |
2022-11-01 |
Hoffmann La Roche |
Enzyme and pathway modulation with sulfhydryl compounds and their derivatives
|
|
CN115867304A
(zh)
|
2020-05-19 |
2023-03-28 |
欧萨尔普罗席纳有限公司 |
用于治疗阿兹海默症的多抗原决定基疫苗
|
|
JP2023528797A
(ja)
|
2020-05-26 |
2023-07-06 |
トゥルーバインディング，インコーポレイテッド |
ガレクチン－３を遮断することにより炎症性疾患を処置する方法
|
|
US20230226016A1
(en)
|
2020-05-29 |
2023-07-20 |
The Regents Of University Of California |
Agents and methods for treating tauopathies
|
|
US20230235075A1
(en)
|
2020-06-02 |
2023-07-27 |
Dynamicure Biotechnology Llc |
Anti-cd93 constructs and uses thereof
|
|
CN116529260A
(zh)
|
2020-06-02 |
2023-08-01 |
当康生物技术有限责任公司 |
抗cd93构建体及其用途
|
|
TWI838626B
(zh)
|
2020-06-03 |
2024-04-11 |
美商基利科學股份有限公司 |
Lpa受體拮抗劑及其用途
|
|
WO2021248081A1
(en)
|
2020-06-05 |
2021-12-09 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Acvr1 (alk2) receptor inhibition to treat neurological diseases
|
|
KR102225447B1
(ko)
|
2020-06-16 |
2021-03-08 |
부산대학교 산학협력단 |
구강 세균의 군집을 이용한 알츠하이머 진단용 바이오마커 및 이의 용도
|
|
CN115916827A
(zh)
|
2020-06-19 |
2023-04-04 |
豪夫迈·罗氏有限公司 |
免疫活化Fc结构域结合分子
|
|
TW202216188A
(zh)
|
2020-06-25 |
2022-05-01 |
英商梅迪繆思有限公司 |
軸突損傷之預防
|
|
US20210403644A1
(en)
|
2020-06-29 |
2021-12-30 |
University Of South Carolina |
Method For The Degradation Of Endogenous Protein
|
|
EP4173636A4
(en)
|
2020-06-30 |
2024-08-28 |
Shionogi & Co., Ltd |
Combined use of anti-ccr8 antibody and chemotherapeutic agent
|
|
WO2022011358A1
(en)
|
2020-07-10 |
2022-01-13 |
Biomolecular Holdings Llc |
Tetrahedral antibodies
|
|
AU2021313881A1
(en)
|
2020-07-20 |
2023-02-23 |
Neotx Therapeutics Ltd. |
Superantigen conjugate for use in methods and compositions for treating cancer
|
|
MX2023000877A
(es)
|
2020-07-20 |
2023-02-22 |
Genentech Inc |
Metodos para la caracterizacion de anticuerpos de tipo del medio hacia abajo.
|
|
CA3184999A1
(en)
|
2020-07-21 |
2022-01-27 |
Volker Schellenberger |
Compositions and methods related to activatable therapeutic agents
|
|
AU2021315665A1
(en)
|
2020-07-29 |
2023-03-16 |
Dynamicure Biotechnology Llc |
Anti-CD93 constructs and uses thereof
|
|
BR112023000848A2
(pt)
|
2020-07-30 |
2023-02-07 |
Unigen Inc |
Composição de bioflavonoide padronizada para regulação de homeostase de mecanismo de defesa de hospedeiro
|
|
CN116406295A
(zh)
|
2020-07-30 |
2023-07-07 |
安奈普泰斯生物有限公司 |
针对鱼鳞病的抗白介素36受体（il-36r）疗法
|
|
WO2022031749A1
(en)
|
2020-08-03 |
2022-02-10 |
Genentech, Inc. |
Diagnostic and therapeutic methods for lymphoma
|
|
CA3185687A1
(en)
|
2020-08-03 |
2022-02-10 |
F. Hoffmann-La Roche Ag |
Improved antigen binding receptors
|
|
CA3188458A1
(en)
|
2020-08-07 |
2022-02-10 |
Robin Barbour |
Tau vaccine for the treatment of alzheimer's disease
|
|
AU2021321549A1
(en)
|
2020-08-07 |
2023-03-09 |
Othair Prothena Limited |
Multiepitope vaccine for the treatment of alzheimer's disease
|
|
KR102799318B1
(ko)
|
2020-08-11 |
2025-04-23 |
주식회사 카나프테라퓨틱스 |
Il-12 및 항-fap 항체를 포함하는 융합단백질 및 이의 용도
|
|
EP4186926A4
(en)
|
2020-08-28 |
2024-06-05 |
Harbour Biomed US, Inc. |
ANTI-CCR8 ANTIBODIES AND CORRESPONDING APPLICATION
|
|
JP7510518B2
(ja)
|
2020-09-01 |
2024-07-03 |
レメゲン シーオー．，エルティーディー． |
抗ｃ－Ｍｅｔ抗体薬物複合体及びその応用
|
|
JP2023541669A
(ja)
|
2020-09-17 |
2023-10-03 |
オター プロシーナ リミテッド |
アルツハイマー病の処置のためのβ－アミロイドワクチン
|
|
AU2021345483A1
(en)
|
2020-09-18 |
2023-04-13 |
Othair Prothena Limited |
Multiepitope vaccine for the treatment of alzheimer's disease
|
|
WO2022058505A1
(en)
|
2020-09-18 |
2022-03-24 |
Pieris Pharmaceuticals Gmbh |
Biomarker methods and uses
|
|
KR20230074146A
(ko)
|
2020-09-24 |
2023-05-26 |
에프. 호프만-라 로슈 아게 |
T 세포 이중특이성 항체 관련 역효과의 예방 또는 완화
|
|
WO2022072538A1
(en)
|
2020-09-30 |
2022-04-07 |
Biotheryx, Inc. |
Antibody-drug conjugates, pharmaceutical compositions thereof, and their therapeutic applications
|
|
JP2023545057A
(ja)
|
2020-10-07 |
2023-10-26 |
ドレン バイオ， インコーポレイテッド |
抗デクチン－１抗体及びその使用方法
|
|
WO2022078277A1
(en)
|
2020-10-16 |
2022-04-21 |
Lanova Medicines Limited Company |
Anti-ccr8 monoclonal antibodies and uses thereof
|
|
CN116507640A
(zh)
|
2020-10-28 |
2023-07-28 |
豪夫迈·罗氏有限公司 |
改善的抗原结合受体
|
|
CA3196810A1
(en)
|
2020-11-10 |
2022-05-19 |
F. Hoffmann-La Roche Ag |
Prevention or mitigation of t-cell engaging agent-related adverse effects
|
|
WO2022125482A1
(en)
|
2020-12-08 |
2022-06-16 |
Memorial Sloan Kettering Cancer Center |
Antibodies to galectin-3 and methods of use thereof
|
|
CN114656562B
(zh)
|
2020-12-23 |
2023-11-03 |
北京天广实生物技术股份有限公司 |
结合人和猴cd3的抗体及其应用
|
|
WO2022148732A1
(en)
|
2021-01-06 |
2022-07-14 |
F. Hoffmann-La Roche Ag |
Combination therapy employing a pd1-lag3 bispecific antibody and a cd20 t cell bispecific antibody
|
|
WO2022150644A1
(en)
|
2021-01-08 |
2022-07-14 |
Anaptysbio, Inc. |
Anti-interleukin 36 receptor (il-36r) therapy for acne
|
|
WO2022150642A1
(en)
|
2021-01-08 |
2022-07-14 |
Anaptysbio, Inc. |
Anti-interleukin 36 receptor (il-36r) therapy for hidradenitis suppurativa
|
|
EP4284824A4
(en)
|
2021-01-27 |
2025-03-12 |
AbelZeta Inc. |
CHIMERIC ANTIGEN RECEPTORS TARGETING CD20
|
|
KR102549520B1
(ko)
|
2021-01-29 |
2023-07-03 |
일리미스테라퓨틱스 주식회사 |
비염증성 식세포작용 유도 활성을 갖는 융합분자
|
|
AU2022224066A1
(en)
|
2021-02-19 |
2023-09-07 |
Angeles Therapeutics, Inc. |
Single-chain and multi-chain synthetic antigen receptors for diverse immune cells
|
|
WO2022198192A1
(en)
|
2021-03-15 |
2022-09-22 |
Genentech, Inc. |
Compositions and methods of treating lupus nephritis
|
|
JP2024511360A
(ja)
|
2021-03-18 |
2024-03-13 |
シージェン インコーポレイテッド |
生体活性化合物の内部移行複合体からの選択的薬物放出
|
|
AU2022238571A1
(en)
|
2021-03-18 |
2023-09-14 |
Seagen Inc. |
Selective drug release from internalized conjugates of biologically active compounds
|
|
AU2022241940A1
(en)
|
2021-03-23 |
2023-10-26 |
Pieris Pharmaceuticals Gmbh |
Her2/4-1bb bispecific fusion proteins for the treatment of cancer
|
|
CA3212978A1
(en)
|
2021-03-24 |
2022-09-29 |
James N. KOCHENDERFER |
Bicistronic chimeric antigen receptors designed to reduce retroviral recombination and uses thereof
|
|
WO2022200478A1
(en)
|
2021-03-24 |
2022-09-29 |
Pieris Pharmaceuticals Gmbh |
Tumor treatment with a 4-1bb/her2-bispecific agent and a her2-targeted tyrosine kinase inhibitor
|
|
MX2023011310A
(es)
|
2021-03-26 |
2023-10-05 |
Innate Pharma |
Anclajes de citocina para proteinas de celulas nk de union a nkp46.
|
|
CA3212756A1
(en)
|
2021-04-02 |
2022-10-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Bispecific molecules and related compositions and methods
|
|
KR20230171980A
(ko)
|
2021-04-20 |
2023-12-21 |
씨젠 인크. |
항체 의존성 세포 독성의 조절
|
|
CN117222412A
(zh)
|
2021-04-23 |
2023-12-12 |
豪夫迈·罗氏有限公司 |
Nk细胞接合剂相关的不良反应的预防或减轻
|
|
JP2024515968A
(ja)
|
2021-04-26 |
2024-04-11 |
トゥルーバインディング，インコーポレイテッド |
抗ｇａｌ３抗体製剤およびその使用法
|
|
WO2022228706A1
(en)
|
2021-04-30 |
2022-11-03 |
F. Hoffmann-La Roche Ag |
Dosing for treatment with anti-cd20/anti-cd3 bispecific antibody
|
|
JP2024517535A
(ja)
|
2021-04-30 |
2024-04-23 |
エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト |
抗ｃｄ２０／抗ｃｄ３二重特異性抗体と抗ｃｄ７９ｂ抗体薬物コンジュゲートを用いた併用治療の投与
|
|
WO2022235622A2
(en)
|
2021-05-04 |
2022-11-10 |
Biocove Llc |
Cd20 targeting fusion proteins and methods of use thereof
|
|
BR112023023622A2
(pt)
|
2021-05-12 |
2024-02-06 |
Genentech Inc |
Métodos para tratar linfoma difuso, kits, imunoconjugados, polatuzumabe vedotina e imunoconjugado para uso
|
|
CA3218343A1
(en)
|
2021-05-12 |
2022-11-17 |
Anaptysbio, Inc. |
Antibody composition
|
|
WO2022240741A1
(en)
|
2021-05-12 |
2022-11-17 |
Dana-Farber Cancer Institute, Inc. |
Lag3 and gal3 inhibitory agents, xbp1, cs1, and cd138 peptides, and methods of use thereof
|
|
CA3221398A1
(en)
|
2021-05-28 |
2022-12-01 |
Seagen Inc. |
Anthracycline antibody conjugates
|
|
AR126009A1
(es)
|
2021-06-02 |
2023-08-30 |
Hoffmann La Roche |
Moléculas agonistas de unión al antígeno cd28 que se dirigen a epcam
|
|
US11987636B2
(en)
|
2021-06-04 |
2024-05-21 |
Xencor, Inc. |
Dosing of a bispecific antibody that binds CD20 and CD3
|
|
JP2024524870A
(ja)
|
2021-06-08 |
2024-07-09 |
トゥルーバインディング，インコーポレイテッド |
抗ｇａｌ３抗体およびインスリン抵抗性に使用する方法
|
|
WO2022258678A1
(en)
|
2021-06-09 |
2022-12-15 |
Innate Pharma |
Multispecific proteins binding to nkp30, a cytokine receptor, a tumour antigen and cd16a
|
|
JP2024523838A
(ja)
|
2021-06-09 |
2024-07-02 |
シャンハイ エピムアブ バイオセラピューティクス カンパニー リミテッド |
Ｏｘ４０及び／又はｐｄ－ｌ１に結合する抗体及び二重特異性結合タンパク質
|
|
IL308531A
(en)
|
2021-06-09 |
2024-01-01 |
Innate Pharma |
Multispecific antibodies binding to cd20, nkp46, cd16 and conjugated to il-2
|
|
CA3218793A1
(en)
|
2021-06-09 |
2022-12-15 |
Laurent Gauthier |
Multispecific proteins binding to nkp46, a cytokine receptor, a tumour antigen and cd16a
|
|
WO2022258691A1
(en)
|
2021-06-09 |
2022-12-15 |
Innate Pharma |
Multispecific proteins binding to nkg2d, a cytokine receptor, a tumour antigen and cd16a
|
|
WO2022266540A2
(en)
|
2021-06-18 |
2022-12-22 |
Therini Bio, Inc. |
ANTIBODIES WHICH BIND HUMAN FIBRIN OR FIBRINOGEN γC DOMAIN AND METHODS OF USE
|
|
JP2024522237A
(ja)
|
2021-06-18 |
2024-06-11 |
セリーニ バイオ インコーポレイテッド |
ヒトフィブリンまたはフィブリノゲンγＣドメインに結合する抗体および使用方法
|
|
CN117157098A
(zh)
|
2021-06-22 |
2023-12-01 |
荣昌生物制药(烟台)股份有限公司 |
一种药物组合及其用途
|
|
JP2024527288A
(ja)
|
2021-06-25 |
2024-07-24 |
ナンキン イムノファージ バイオテック カンパニー リミテッド |
抗ｃｃｒ８抗体及びその使用
|
|
JP2024526297A
(ja)
|
2021-07-09 |
2024-07-17 |
ブライト ピーク セラピューティクス エージー |
抗体コンジュゲートおよびその製造
|
|
WO2023281482A1
(en)
|
2021-07-09 |
2023-01-12 |
Bright Peak Therapeutics Ag |
Cd20-targeted il-2 and its uses
|
|
EP4371125A1
(en)
|
2021-07-13 |
2024-05-22 |
Genentech, Inc. |
Multi-variate model for predicting cytokine release syndrome
|
|
US20250026838A1
(en)
|
2021-07-13 |
2025-01-23 |
Truebinding, Inc. |
Methods of preventing protein aggregation
|
|
JP2024525727A
(ja)
|
2021-07-14 |
2024-07-12 |
２セブンティ バイオ インコーポレイテッド |
抗体由来の結合ドメインに融合した操作されたｔ細胞受容体
|
|
KR20240036570A
(ko)
|
2021-07-22 |
2024-03-20 |
에프. 호프만-라 로슈 아게 |
이종이량체 Fc 도메인 항체
|
|
US20240336697A1
(en)
|
2021-08-07 |
2024-10-10 |
Genentech, Inc. |
Methods of using anti-cd79b immunoconjugates to treat diffuse large b-cell lymphoma
|
|
US20240353426A1
(en)
|
2021-08-13 |
2024-10-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for Diagnosing and Treating Ischemic Eye Disease
|
|
CN118317979A
(zh)
|
2021-09-29 |
2024-07-09 |
摩德斯医疗股份有限公司 |
抗原结合多肽、抗原结合多肽复合物及其使用方法
|
|
AU2022356387A1
(en)
|
2021-09-29 |
2024-04-18 |
Modex Therapeutics, Inc. |
Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof
|
|
WO2023051727A1
(zh)
|
2021-09-30 |
2023-04-06 |
上海君实生物医药科技股份有限公司 |
结合cd3的抗体及其用途
|
|
AR127271A1
(es)
|
2021-10-09 |
2024-01-03 |
Hutchmed Ltd |
Anticuerpos biespecíficos que se unen específicamente a cd47 y cd20, y usos de los mismos
|
|
CN115746134A
(zh)
|
2021-10-15 |
2023-03-07 |
深圳市睿盟创新生物科技有限公司 |
半乳糖凝集素-3的免疫测定
|
|
KR20230060546A
(ko)
|
2021-10-22 |
2023-05-04 |
상트네어바이오사이언스 주식회사 |
두개의 Fc 도메인을 포함하는 항원 결합 단백질 및 이의 용도
|
|
CA3235789A1
(en)
|
2021-10-29 |
2023-05-04 |
Kimberly Kelly |
Cancer specific plectin-1 specific antibodies and methods of use thereof
|
|
CN118524852A
(zh)
|
2021-11-09 |
2024-08-20 |
真和制药有限公司 |
治疗或抑制心血管疾病的方法
|
|
JP2024543152A
(ja)
|
2021-11-25 |
2024-11-19 |
エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト |
改善された抗原結合受容体
|
|
WO2023109942A1
(en)
|
2021-12-17 |
2023-06-22 |
Jacobio Pharmaceuticals Co., Ltd. |
Compound-linker constructs comprising novel compounds useful as sting agonists and uses thereof
|
|
CN118742637A
(zh)
|
2021-12-23 |
2024-10-01 |
乐普创一生物科技（上海）有限公司 |
抗ccr8抗体及其应用
|
|
CN118591561A
(zh)
|
2021-12-29 |
2024-09-03 |
四川汇宇制药股份有限公司 |
靶向cd3的抗体及多特异性抗体及其用途
|
|
WO2023137387A2
(en)
|
2022-01-12 |
2023-07-20 |
Biomolecular Holdings Llc |
Tetrahedral antibodies
|
|
WO2023137373A1
(en)
|
2022-01-12 |
2023-07-20 |
Biomolecular Holdings Llc |
Tetrahedral antibodies
|
|
US20250154275A1
(en)
|
2022-01-20 |
2025-05-15 |
Shanghai Junshi Biosciences Co., Ltd. |
Anti-cd3 and anti-cd20 bispecific antibody and use thereof
|
|
CN119053342A
(zh)
|
2022-01-21 |
2024-11-29 |
礼进生物医药控股有限公司 |
用于亲合力受体交联和免疫调节的多特异性抗体
|
|
KR20230119859A
(ko)
|
2022-02-08 |
2023-08-16 |
연세대학교 산학협력단 |
신규 이중타겟 융합항체를 유효성분으로 포함하는 암의 예방 또는 치료용 조성물
|
|
TW202400643A
(zh)
|
2022-02-28 |
2024-01-01 |
日商帝人製藥股份有限公司 |
神經退化性疾病之治療劑
|
|
GB202203070D0
(en)
|
2022-03-04 |
2022-04-20 |
Iksuda Therapeutics Ltd |
Anti-canag antibody conjugate
|
|
PE20242179A1
(es)
|
2022-03-17 |
2024-11-07 |
Seagen Inc |
Conjugados de camptotecina
|
|
CN116789820A
(zh)
|
2022-03-18 |
2023-09-22 |
北京天诺健成医药科技有限公司 |
一种新型免疫调节剂的开发和应用
|
|
AU2023238766A1
(en)
|
2022-03-23 |
2024-07-25 |
F. Hoffmann-La Roche Ag |
Combination treatment of an anti-cd20/anti-cd3 bispecific antibody and chemotherapy
|
|
EP4499685A1
(en)
|
2022-03-25 |
2025-02-05 |
CytomX Therapeutics, Inc. |
Activatable dual-anchored masked molecules and methods of use thereof
|
|
WO2023180533A1
(en)
|
2022-03-25 |
2023-09-28 |
Les Laboratoires Servier |
Anti-gal3 antibodies and compositions
|
|
CN119213033A
(zh)
|
2022-04-04 |
2024-12-27 |
德伦生物公司 |
结合Dectin-1和CD20的多特异性结合蛋白和其使用方法
|
|
KR20250006353A
(ko)
|
2022-04-04 |
2025-01-10 |
드렌 바이오, 인크. |
항-덱틴-1 항체 및 이의 사용 방법
|
|
KR20250008809A
(ko)
|
2022-04-08 |
2025-01-15 |
리제너론 파마슈티칼스 인코포레이티드 |
다분할 수용체 및 신호전달 복합체
|
|
CN118974091A
(zh)
|
2022-04-11 |
2024-11-15 |
阿斯利康(瑞典)有限公司 |
T细胞结合蛋白
|
|
KR20250004768A
(ko)
|
2022-04-13 |
2025-01-08 |
제넨테크, 인크. |
치료 단백질의 약학적 조성물 및 사용 방법
|
|
CA3255366A1
(en)
|
2022-04-13 |
2023-10-19 |
F. Hoffmann-La Roche Ag |
Pharmaceutical compositions based on bispecific anti-CD20/anti-CD3 antibodies and methods of use
|
|
CA3255890A1
(en)
|
2022-04-15 |
2023-10-19 |
Mabsoft Therapeutics (Shanghai) Co., Ltd. |
CONJUGATE COMPRISING A TOLL-TYPE RECEPTOR AGONIST
|
|
CN117003872A
(zh)
|
2022-04-28 |
2023-11-07 |
北京天广实生物技术股份有限公司 |
含有突变轻链可变区骨架的单链抗体片段
|
|
CN119546335A
(zh)
|
2022-05-03 |
2025-02-28 |
Xencor股份有限公司 |
治疗淋巴瘤的方法
|
|
US20250255981A1
(en)
|
2022-05-06 |
2025-08-14 |
Seagen Inc. |
Immunomodulatory antibody-drug conjugates
|
|
WO2023227660A1
(en)
|
2022-05-25 |
2023-11-30 |
Innate Pharma |
Nectin-4 binding agents
|
|
US20230416412A1
(en)
|
2022-05-31 |
2023-12-28 |
Hoffmann-La Roche Inc. |
Prevention or mitigation of t-cell engaging agent-related adverse effects
|
|
WO2024001641A1
(zh)
|
2022-07-01 |
2024-01-04 |
广东克冠达医药科技有限公司 |
Cd101的抗体及其用途
|
|
AR129896A1
(es)
|
2022-07-12 |
2024-10-09 |
Cytomx Therapeutics Inc |
INMUNOCONJUGADOS DE EpCAM Y USOS DE ESTOS
|
|
WO2024026407A1
(en)
|
2022-07-28 |
2024-02-01 |
The Board Of Regents Of The University Of Oklahoma |
Biomarkers, diagnostic methods, treatments, and therapeutics for autoimmune disorders and diseases
|
|
IL318450A
(en)
|
2022-08-03 |
2025-03-01 |
Seagen Inc |
Immunostimulatory ANTI-PD-L1-Drug conjugates
|
|
WO2024036148A1
(en)
|
2022-08-08 |
2024-02-15 |
A2 Biotherapeutics, Inc. |
Compositions and methods for treating blood cancers
|
|
EP4321522A1
(en)
|
2022-08-12 |
2024-02-14 |
Seagen Inc. |
Cytotoxic compounds and conjugates thereof
|
|
WO2024040194A1
(en)
|
2022-08-17 |
2024-02-22 |
Capstan Therapeutics, Inc. |
Conditioning for in vivo immune cell engineering
|
|
CN117051537A
(zh)
|
2023-07-03 |
2023-11-14 |
五邑大学 |
一种乙酰化葡甘聚糖静电纺丝膜及其制备方法与应用
|